Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 52
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

GSR-DB, a manually curated and optimized taxonomical database for 16S rRNA amplicon analysis

  • Molano, L.A.G.|||0000-0003-0069-6098
  • Vega-Abellaneda, Sara
  • Manichanh, Chaysavanh|||0000-0002-2287-4003
Taxonomic assignments of microorganisms have long been hindered by inconsistent nomenclature and annotation issues in existing databases like SILVA, Greengenes, Greengenes2, Genome Taxonomy Database, or Ribosomal Database Project. To overcome these issues, we created Greengenes-SILVA-RDP database (GSR-DB), accurate and comprehensive taxonomic annotations of 16S amplicon data. Unlike previous approaches, our innovative pipeline includes a unique taxonomy unification step, ensuring consistent and reliable annotations. Our evaluation analyses showed that GSR-DB outperforms existing databases in providing species-level resolution, especially based on mock-community analysis, making it a game-changer for microbiome studies. Moreover, GSR-DB is designed to be accessible to researchers with limited computational resources, making it a powerful tool for scientists across the board. Available for full-length 16S sequences and commonly used hypervariable regions, including V4, V1-V3, V3-V4, and V3-V5, GSR-DB is a go-to database for robust and accurate microbial taxonomy analysis.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

The Effect of Probiotics on Preterm Birth Rates in Pregnant Women After a Threatened Preterm Birth Episode (The PROPEV Trial)

  • del Barco, E.
  • Molano, L.A.G.|||0000-0003-0069-6098
  • Vargas Buján, Mireia|||0000-0002-4980-7652
  • Miserachs, M.|||0000-0002-7946-3635
  • Puerto Tamayo, Linda Grace|||0000-0001-5539-6397
  • Garrido-Giménez, Carmen|||0000-0003-2180-1715
  • Soler, Z.
  • Muñoz, B.
  • Pratcorona, L.
  • Rimbaut, S.
  • Vidal, M.
  • Dalmau, M.
  • Casellas, A.
  • Carreras, Enric|||0000-0002-3134-9964
  • Manichanh, Chaysavanh|||0000-0002-2287-4003
  • Goya, M.|||0000-0003-4001-2017
Introduction: Preterm birth is the leading cause of perinatal mortality worldwide, with prevalence rates showing little reduction. Although mortality rates have decreased, morbidity rates remain concerningly high. In recent years, there has been a surge in studies examining the etiology, risk factors, and management of preterm birth. The use of vaginal probiotics in pregnant women at risk of preterm birth has garnered attention as a potential approach for improving perinatal outcomes and modulating the vaginal microbiota. However, the efficacy of this intervention remains unclear. Therefore, this study explored the impact of vaginal probiotics on perinatal outcomes and vaginal microbiota composition in pregnant women at risk of preterm birth. Materials and Methods: This was a randomized, prospective, longitudinal, double-blind, placebo-controlled, multicentric trial conducted across seven maternities in Spain from October 2017 to August 2022 in pregnant women at risk of preterm birth. Participants were randomly assigned to receive vaginal probiotics containing four lactobacilli strains or a placebo. The primary outcome was to explore a potential correlation between probiotic use among pregnant women at risk of preterm birth and the actual rate of preterm birth before 37 gestational weeks. Secondary outcomes included an evaluation of preterm birth rates, neonatal morbidity, the vaginal microbiota, and changes in the vaginal microbiota after receiving probiotics. Other secondary outcomes were identifying vaginal microbiota patterns associated with preterm birth and exploring potential therapeutic mechanisms involving probiotics. Trial registration: Clinicaltrials.gov, identifier: NCT03689166. Results: A total of 200 participants were included. Of those, birth data were obtained for 181 women. Demographics were similar between both groups. An analysis of perinatal outcomes found no significant differences in preterm birth rates, prematurity rates, gestational weeks at delivery, neonatal complications, time to birth, or latency time to delivery. Microbiota analysis showed no significant differences in vaginal microbiota changes between groups. No serious or unexpected adverse reactions were reported. Conclusions: There were no statistically significant differences for spontaneous preterm birth between pregnant women receiving probiotics and pregnant women receiving the placebo.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Distinct microbial mediators link diet to inflammation in Crohn's disease and ulcerative colitis

  • Mayorga, Luis
  • Noguera Segura, Arnau
  • Campderrós, Laura
  • Pons-Tarin, Marc
  • Soler, Zaida|||0000-0003-1709-8721
  • Vega-Abellaneda, Sara
  • Serrano-Gómez, Gerard|||0000-0002-9447-3778
  • Herrera-deGuise, Claudia|||0000-0003-2721-3471
  • Robles, Virginia|||0000-0003-2580-0699
  • Borruel, Natalia|||0000-0002-4449-2292
  • Manichanh, Chaysavanh|||0000-0002-2287-4003
Background Inflammatory bowel disease (IBD) arises from complex interactions among diet, host and gut microbiome. Although diet influences intestinal inflammation, the microbial and metabolic pathways involved, and their differences between Crohn's disease (CD) and ulcerative colitis (UC), the two main subtypes of IBD remain unclear. Objective To investigate how the gut microbiome mediates the effects of habitual diet on inflammatory activity in IBD. Design This longitudinal study included 198 adults (100 healthy controls, 49 CD, 49 UC), participants completed a validated food frequency questionnaire. Dietary quality was evaluated using established indices (Alternative Mediterranean Diet, Healthy Eating Index-2015, Índice de Alimentación Saludable, Mean Adequacy Ratio, Plant-Based Dietary Indexes, Healthy Food Diversity). Participants also provided two stool samples (baseline and 6months). Shotgun metagenomics (n=366) enabled taxonomic and functional profiling. Causal mediation analyses were used to identify microbial features mediating the effect of diet on inflammation. Results IBD patients exhibited lower dietary diversity, fibre intake and nutritional adequacy compared with controls. Microbiome diversity was lowest in CD, intermediate in UC and correlated positively with higher intake of fibre, fruit, vegetables and nuts, and negative with processed foods and sugary beverages. Causal mediation analyses revealed that in CD, coffee, whole wheat bread and healthier diets lowered the Harvey-Bradshaw index through specific bacterial species and metabolites. In UC, Mediterranean-like diets, fruits and coffee reduced C reactive protein via greater microbial richness, reduced dysbiosis and short-chain fatty acid-related functions. Conclusion Diet quality influences inflammation in IBD through distinct microbiome pathways: specific taxa and metabolites mediate effects in CD, whereas microbial richness and global composition drive protection in UC.
Repisalud
Publication Artículo científico (JournalArticle)

Isolation and Characterization of Milk Exosomes for Use in Advanced Therapies

  • Medel-Martínez, Ana
  • Redrado-Osta, Ana
  • Crespo-Barreda, Alejandra
  • Sancho-Albero, Maria
  • Sánchez, Lourdes
  • Sebastián, Víctor
  • Pardo, María
  • De la Vieja, Antonio
  • Martin-Duque, Pilar
Exosomes are cell-derived extracellular vesicles (EVs) with diameters between 30 and 120 nm. In recent years, several studies have evaluated the therapeutic potential of exosomes derived from different fluids due to their low immunogenicity and high biocompatibility. However, producing exosomes on a large scale is still challenging. One of the fluids from which they could be isolated in large quantities is milk. Moreover, regeneration is a well-known property of milk. The present work seeks to optimize a method for isolating exosomes from bovine and human milk, comparing different storage conditions and different extraction protocols. We found differences in the yield extraction associated with pre-storage milk conditions and observed some differences according to the processing agent. When we removed milk fat globules and added rennet before freezing, we obtained a cleaner final fraction. In summary, we attempted to optimize a rennet-based new milk-exosome isolation method and concluded that pre-treatment, followed by freezing of samples, yielded the best exosome population.
Repisalud
Publication Artículo científico (JournalArticle)

Nrf2 Plays a Protective Role Against Intravascular Hemolysis-Mediated Acute Kidney Injury

  • Rubio-Navarro, Alfonso
  • Vázquez-Carballo, Cristina
  • Guerrero-Hue, Melania
  • García-Caballero, Cristina
  • Herencia, Carmen
  • Gutiérrez, Eduardo
  • Yuste, Claudia
  • Sevillano, Ángel
  • Praga, Manuel
  • Egea, Javier
  • Cannata, Pablo
  • Cortegano, Isabel
  • Andres, Belen de
  • Gaspar, Maria Luisa
  • Cadenas, Susana
  • Michalska, Patrycja
  • León, Rafael
  • Ortiz, Alberto
  • Egido, Jesús
  • Moreno, Juan Antonio
Massive intravascular hemolysis is associated with acute kidney injury (AKI). Nuclear factor erythroid-2-related factor 2 (Nrf2) plays a central role in the defense against oxidative stress by activating the expression of antioxidant proteins. We investigated the role of Nrf2 in intravascular hemolysis and whether Nrf2 activation protected against hemoglobin (Hb)/heme-mediated renal damage in vivo and in vitro. We observed renal Nrf2 activation in human hemolysis and in an experimental model of intravascular hemolysis promoted by phenylhydrazine intraperitoneal injection. In wild-type mice, Hb/heme released from intravascular hemolysis promoted AKI, resulting in decreased renal function, enhanced expression of tubular injury markers (KIM-1 and NGAL), oxidative and endoplasmic reticulum stress (ER), and cell death. These features were more severe in Nrf2-deficient mice, which showed decreased expression of Nrf2-related antioxidant enzymes, including heme oxygenase 1 (HO-1) and ferritin. Nrf2 activation with sulforaphane protected against Hb toxicity in mice and cultured tubular epithelial cells, ameliorating renal function and kidney injury and reducing cell stress and death. Nrf2 genotype or sulforaphane treatment did not influence the severity of hemolysis. In conclusion, our study identifies Nrf2 as a key molecule involved in protection against renal damage associated with hemolysis and opens novel therapeutic approaches to prevent renal damage in patients with severe hemolytic crisis. These findings provide new insights into novel aspects of Hb-mediated renal toxicity and may have important therapeutic implications for intravascular hemolysis-related diseases.
Repisalud
Publication Artículo científico (JournalArticle)

Toll-Like Receptors in Acute Kidney Injury.

  • Vázquez-Carballo, Cristina
  • Guerrero-Hue, Melania
  • García-Caballero, Cristina
  • Rayego-Mateos, Sandra
  • Opazo-Ríos, Lucas
  • Morgado-Pascual, José Luis
  • Herencia-Bellido, Carmen
  • Vallejo-Mudarra, Mercedes
  • Cortegano, Isabel
  • Gaspar, Maria Luisa
  • Andres, Belen de
  • Egido, Jesús
  • Moreno, Juan Antonio
Acute kidney injury (AKI) is an important health problem, affecting 13.3 million individuals/year. It is associated with increased mortality, mainly in low- and middle-income countries, where renal replacement therapy is limited. Moreover, survivors show adverse long-term outcomes, including increased risk of developing recurrent AKI bouts, cardiovascular events, and chronic kidney disease. However, there are no specific treatments to decrease the adverse consequences of AKI. Epidemiological and preclinical studies show the pathological role of inflammation in AKI, not only at the acute phase but also in the progression to chronic kidney disease. Toll-like receptors (TLRs) are key regulators of the inflammatory response and have been associated to many cellular processes activated during AKI. For that reason, a number of anti-inflammatory agents targeting TLRs have been analyzed in preclinical studies to decrease renal damage during AKI. In this review, we updated recent knowledge about the role of TLRs, mainly TLR4, in the initiation and development of AKI as well as novel compounds targeting these molecules to diminish kidney injury associated to this pathological condition.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Assessment of the stability of LTA zeolites under natural gas drying TSA conditions

  • Moura, P.A.S.
  • Ferracine, E.D.S.
  • Rodríguez-Aguado, E.
  • Maia, D.A.S.
  • Melo, D. C.
  • Cardoso, D.
  • Bastos-Neto, M.
  • Rodríguez-Castellón, E.
  • Azevedo, D.C.S.
  • Valencia Valencia, Susana|||0000-0001-7160-2795
  • Rey Garcia, Fernando|||0000-0003-3227-5669
[EN] The main features in cationic LTA zeolites that are likely to impact its potential hydrothermal stability are interconnected. The Al content and the compensating cation play an important role in the water adsorption but their influence on the zeolite performance in thermal cycles is yet to be understood. In this study, four LTA zeolite samples were synthetized with distinct Si/Al ratios in sodium and potassium forms. They underwent a Premature Aging Protocol (PAP) that took into account the operating conditions typically found in temperature swing adsorption processes. The Si/Al ratio per se did not impact in the crystallinity upon aging, but the presence of a high amount of potassium cations (Si/Al = 1) led to the amorphization of the zeolite structure. The results from XPS and NMR techniques indicate the Al migration from the outer surface to the inner cages occurs upon aging. Chemical analysis by XRF and ICP-OES associated with 27Al NMR analysis reveal that the presence of EFAl is particularly significant in the sample with the largest Si/Al ratio (5) and is correlated to a much larger C deposition upon aging. TG/DTG and TPD-NH3 experiments suggest that acid sites in the zeolite structures act as a double-edged sword, by enhancing water adsorption while also leading to carbon accumulation. CO2 isotherms at 0 oC reveal the reduction of the microporosity after aging, whereas the Al content is proportional to the water adsorption uptake, particularly at low pressures (below 10 mbar). The material with an intermediate Si/Al ratio and in Na-form (LTAc-SiAl2-Na) combines excellent hydrothermal stability with a high-water affinity and uptake., The authors acknowledge financial support from Petrobras (Brazil) project 2018/00130-5, CAPES (Brazil), particularly in the frame of project CAPES/Print 88887.311867/2018-00 and Servicios Centrales de Apoyo a la Investigacion - SCAI. S.V. and F. R. acknowledge financial support by the Spanish Ministry of Science and Innovation (CEX2021-001230-S grant funded by MCIN/AEI/10.13039/501100011033 and TED2021-130191B-C41 and TED2021-130756B-C31 grants funded by MCIN/AEI/10.13039/501100011033 and by "ERDF A way of making Europe" by the European Union NextGenerationEU/PRTR). Authors thank also the financial support by the Generalitat Valenciana (Prometeo 2021/077). This study forms part of the Advanced Materials programme and was supported by MCIN with partial funding from European Union Next Generation EU (PRTR-C17. I1) and by Generalitat Valenciana (MFA/2022/047 and MFA/2022/012).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Assessing the Premature Aging of Chabazite in Natural Gas Drying by TSA

  • Moura, Pedro A. S.
  • Rodriguez-Aguado, Elena
  • Maia, Debora A. S.
  • Cecilia, Juan A.
  • Melo, Darley C.
  • Bastos-Neto, Moises
  • Rodriguez-Castellon, Enrique
  • Azevedo, Diana C. S.
  • Valencia Valencia, Susana|||0000-0001-7160-2795
  • Rey Garcia, Fernando|||0000-0003-3227-5669
[EN] Ongoing research on adsorbent deactivation in drying processes has unveiled crucial insights into the loss of performance with prolonged use. Our study builds on previous work by examining the effects of high temperatures, hydrocarbon exposure, and cycle duration on chabazite adsorbents with a Si/Al ratio of approximately 2 and in the sodium form. By aging the material under controlled conditions, we assessed the impact on its structural and textural properties. Our findings reveal that maintaining high temperatures, coupled with exposure to n-heptane vapor, induces a mild degradation of the crystalline structure, with more pronounced effects during longer aging periods. Notably, hydrocarbons play a critical role in adsorbent deactivation, adsorbing in both the inner pores and the outer surface of the zeolite. This leads to a deterioration of the textural characteristics, which directly correlates with an increase in the carbon content of the bulk material. Additionally, samples exposed to n-heptane vapor exhibited a more homogeneous composition compared to those subjected to manual liquid n-heptane addition. Overall, the degree of degradation varies among aged samples, indicating the need for tailored applications based on specific aging conditions., The authors acknowledge financial support from Petrobras (Brazil) project 2018/00130-5, CAPES (Brazil), particularly in the frame of project CAPES/Print 88887.311867/2018-00 and Servicios Centrales de Apoyo a la Investigacion-SCAI. The Article Processing Charge (APC) for this research was funded by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES (ROR identifier: OOxOma614). E. Rodriguez-Aguado, J.A. Cecilia and E. Rodriguez-Castellon thank the Ministry of Science and Innovation (MSI/MCIN) of Spain for the grant of the project PID2021-126235OB-C32 financed by MCIN/AEI/10.13039/501100011033 and FEDER funds. S. Valencia and F. Rey acknowledge AEI (Spain) for Grant PID2022-136934OB-100 funded by MICIU/AEI/10.13039/501100011033 and by ERDF/EU, and Generalitat Valenciana for Prometeo Grant CIPROM/2024/050.
IRTA Pubpro. Open Digital Archive
Publication Artículo científico (JournalArticle)

Chemical markers to distinguish the homoand heterozygous bitter genotype in sweet almond kernels

  • Vichi, Stefania
  • Mayer, Morgana N.
  • León-Cárdenas, Maria G.
  • Quintanilla-Casas, Beatriz
  • Tres, Alba
  • Guardiola, Francesc
  • Batlle, Ignasi
  • Romero, Agustí
Bitterness in almonds is controlled by a single gene (Sk dominant for sweet kernel, sk recessive for bitter kernel) and the proportions of the offspring genotypes (SkSk, Sksk, sksk) depend on the progenitors’ genotype. Currently, the latter is deduced after crossing by recording the phenotype of their descendants through kernel tasting. Chemical markers to early identify parental genotypes related to bitter traits can significantly enhance the efficiency of almond breeding programs. On this basis, volatile metabolites related to almond bitterness were investigated by Solid Phase Microextraction-Gas Chromatography-Mass Spectrometry coupled to univariate and multivariate statistics on 244 homo- and heterozygous samples from 42 different cultivars. This study evidenced the association between sweet almonds’ genotype and some volatile metabolites, in particular benzaldehyde, and provided for the first time chemical markers to discriminate between homo- and heterozygous sweet almond genotypes. Furthermore, a multivariate approach based on independent variables was developed to increase the reliability of almond classification. The Partial Least Square-Discriminant Analysis classification model built with selected volatile metabolites that showed discrimination capacity allowed a 98.0% correct classification. The metabolites identified, in particular benzaldehyde, become suitable markers for the early genotype identification in almonds, while a DNA molecular marker is not yet available., info:eu-repo/semantics/publishedVersion
IRTA Pubpro. Open Digital Archive
Publication Artículo científico (JournalArticle)

El programa de mejora genética de almendro del IRTA: 50 años de actividad (1974-2024)

  • Batlle, Ignasi
  • Calle, Alejandro
  • Vargas, F.J.
En 1974, se inició el programa de mejora genética de almendro del IRTA con el propósito de mejorar la calidad del material vegetal disponible. Durante estos 50 años de actividad, los objetivos han sido la obtención de variedades con características, como floración tardía, autocompatibilidad, alta productividad, calidad del fruto, facilidad de formación y poda, vigor adecuado y resistencia a enfermedades. A lo largo del programa se han realizado 1.226 cruzamientos, polinizado 803.587 flores y evaluado 74.025 seedlings. Como resultado, se han introducido en el mercado siete variedades ('Masbovera', 'Glorieta’, 'Francoli’, 'Vairo', 'Constanti', 'Tarraco' y 'Marinada') y un portainjerto híbrido almendro x melocotonero de bajo vigor ('Intensia') para plantaciones intensivas. Asimismo, varias selecciones avanzadas están en fase final de evaluación. En la última década, el programa también se dedica a mejorar y resintetizar 'Marcona', con el objetivo de obtener una variedad genéticamente similar de floración tardía y autocompatible., El programa de mejora del IRTA se ha financiado fundamentalmente a través proyectos nacionales e internacionales. Los nacionales han sido: SC97-049, RTA01-081, RTA04-030, RTA07-057, TRT2006 -00021-00-00, RTA2011-00130-00- 00, AGL2013-48577-C2-2-R, RTA2017-00084-00-00, PID2020-114648RR-C31, PDC2021-121639-100. El programa de mejora ha contado con la participación técnica de S. Alegre; N.Aletà; P.Arús; J.Clavé; I.Eduardo; L.W. Howard; L. Lipan; M.López; X. Miarnau; M.Mnejja; A.Ninot; F. Pérez de los Cobos; M.A. Romero; A. Romero; M. Rovira; J. Santos; L.Torguet. Respecto al equipo de soporte, el programa ha contado con la participación de L.Abelló, M. Domènech; J. Ma. Fargas; J. Ma. Ferré; J.F. Hermoso; J. Ma. Gener, R. Girabet; R. Magrinyà; E. Martí; J. Pàmies; S.Tost y J. Vergès., info:eu-repo/semantics/publishedVersion
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publication Artículo científico (JournalArticle)

Nrf2 and Heme Oxygenase-1 Involvement in Atherosclerosis Related Oxidative Stress

  • Alonso Piñero, José Ángel
  • González Rovira, Almudena
  • Sánchez Gomar, Ismael
  • Durán Ruiz, María del Carmen
Atherosclerosis remains the underlying process responsible for cardiovascular diseases and the high mortality rates associated. This chronic inflammatory disease progresses with the formation of occlusive atherosclerotic plaques over the inner walls of vascular vessels, with oxidative stress being an important element of this pathology. Oxidation of low-density lipoproteins (ox-LDL) induces endothelial dysfunction, foam cell activation, and inflammatory response, resulting in the formation of fatty streaks in the atherosclerotic wall. With this in mind, different approaches aim to reduce oxidative damage as a strategy to tackle the progression of atherosclerosis. Special attention has been paid in recent years to the transcription factor Nrf2 and its downstream-regulated protein heme oxygenase-1 (HO-1), both known to provide protection against atherosclerotic injury. In the current review, we summarize the involvement of oxidative stress in atherosclerosis, focusing on the role that these antioxidant molecules exert, as well as the potential therapeutic strategies applied to enhance their antioxidant and antiatherogenic properties.
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Antiviral and Antiproliferative Potential of Marine Organisms from the Yucatan Peninsula, Mexico

  • Pech-Puch, Dawrin
  • Berastegui-Cabrera, Judith
  • Pérez Povedano, Mar Anabel
  • Villegas-Hernández, Harold
  • Guillén-Hernández, Sergio
  • Cautain, Bastien
  • Reyes, Fernando
  • Pachón, Jerónimo
  • Gómez, Patricia
  • Rodríguez, Jaime
  • Jiménez, Carlos
  • Sánchez Céspedes, Javier
[Abstract] Viral infections are one of the main human health problems in recent decades and the cancer remains one of the most lethal diseases worldwide. The development of new antiviral drugs for the treatment of human adenovirus (HAdV) infections continues to be a challenging goal for medicinal chemistry. There is no specific antiviral drug approved to treat infections caused by HAdV so far and the off-label treatments currently available show great variability in their effectiveness. In relation to cancer, most of the available drugs are designed to act on specific targets by altering the activity of involved transporters and genes. Taking into account the high antiviral and antiproliferative activity against tumor cell lines displayed by some marine natural products reported in the literature, sixty five marine organisms were selected: 51 sponges (Porifera), 13 ascidians (Chordata), and 1 gorgonian (Cnidaria), collected from Yucatan Peninsula, Mexico, to evaluate their antiviral activity against human adenovirus type 5 (HAdV5) and their anticancer properties against five human tumor cell lines, namely human lung carcinoma (A549), human skin melanoma (A2058), hepatocyte carcinoma (HepG2), breast adenocarcinoma (MCF7), and pancreas carcinoma (MiaPaca-2). Eleven extracts displayed anti-HAdV activity being the organic extracts of Dysidea sp., Agelas citrina, Chondrilla sp., Spongia tubulifera, and Monanchora arbuscula the five most active ones. On the other hand, 24 extracts showed antiproliferative activity against at least one tumor cell line, being the extracts of the ascidian Eudistoma amanitum and the sponge Haliclona (Rhizoniera) curacaoensis the most active ones. This work constitutes the first wide antiviral and antiproliferative screening report of extracts from the marine sponges, ascidians, and a gorgonian collected from the Yucatan Peninsula, Mexico., This work was supported by Grants RTI2018-093634-B-C22 and RTC-2016-4611-1 (AEI/FEDER, EU) from the State Agency for Research (AEI) of Spain, both co-funded by the FEDER Programme from the European Union, BLUEBIOLAB (0474_BLUEBIOLAB_1_E), Programme INTERREG V A of Spain-Portugal (POCTEP). The study was also funded by projects GRC2018/039 and Agrupación Estratégica CICA-INIBIC ED431E 2018/03 (Consejería de Educación, Universidad y Formación Profesional de la Junta de Galicia) from the Xunta de Galicia (autonomous government of the region). DP-P received a fellowship from the program National Council of Science and Technology (CONACYT) of Mexico and the Secretariat of Research, Innovation and Higher Education (SIIES) of Yucatan (Mexico). Also supported by Instituto de Salud Carlos III, Ministerio de Economía, Industria y Competitividad, Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/0009) – co-financed by “A way to achieve Europe” ERDF, the Instituto de Salud Carlos III, Proyectos de Desarrollo Tecnológico en Salud (DTS17/00130 and PI18/01191), and the Spanish Adenovirus Network (AdenoNet, BIO2015/68990-REDT). JS-C is a researcher belonging to the program “Nicolás Monardes” (C-0059-2018), Servicio Andaluz de Salud, Junta de Andalucía, Spain. The antiproliferative studies were financed with internal funds from Fundación MEDINA, Xunta de Galicia; 0474_BLUEBIOLAB_1_E, Xunta de Galicia; GRC2018/039, Xunta de Galicia; ED431E 2018/03, Junta de Andalucía; C-0059-2018
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Dysbiosis: An Indicator of COVID-19 Severity in Critically Ill Patients

  • Cuenca, Silvia
  • Soler, Zaida
  • Serrano-Gómez, Gerard
  • Xie, Zixuan
  • Barquinero, Jordi
  • Roca, Joaquim
  • Sirvent, Jose-Maria
  • Manichanh, Chaysavanh
Here, we examined the dynamics of the gut and respiratory microbiomes in severe COVID-19 patients in need of mechanical ventilation in the intensive care unit (ICU). We recruited 85 critically ill patients (53 with COVID-19 and 32 without COVID-19) and 17 healthy controls (HCs) and monitored them for up to 4 weeks. We analyzed the bacterial and fungal taxonomic profiles and loads of 232 gut and respiratory samples and we measured the blood levels of Interleukin 6, IgG, and IgM in COVID-19 patients. Upon ICU admission, the bacterial composition and load in the gut and respiratory samples were altered in critically ill patients compared with HCs. During their ICU stay, the patients experienced increased bacterial and fungal loads, drastic decreased bacterial richness, and progressive changes in bacterial and fungal taxonomic profiles. In the gut samples, six bacterial taxa could discriminate ICU-COV(+) from ICU-COV(-) cases upon ICU admission and the bacterial taxa were associated according to age, PaO2/FiO2, and CRP levels. In the respiratory samples of the ICU-COV(+) patients, bacterial signatures including Pseudomonas and Streptococcus were found to be correlated with the length of ICU stay. Our findings demonstrated that the gut and respiratory microbiome dysbiosis and bacterial signatures associated with critical illness emerged as biomarkers of COVID-19 severity and could be a potential predictor of ICU length of stay. We propose using a high-throughput sequencing approach as an alternative to traditional isolation techniques to monitor ICU patient infection., Zixuan Xie received a fellowship from the European Union’s Horizon 2020 research and innovation program under the Marie Sklodowska-Curie Action, Innovative Training Network: FunHoMic (grant number: 812969). Zaida Soler received a fellowship from Instituto de Salud Carlos III/FEDER (fellowship number: FI21/00262). Chaysavanh Manichanh received grants from the Instituto de Salud Carlos III/FEDER (grant numbers PI17/00614; PI20/00130)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Research data Set de datos (Dataset)

Supplementary materials for X-ray Photoelectron Spectroscopy (XPS) analysis of nitrogen environment in small extracellular vesicle membranes: a potential novel technique with application for cancers screening [Dataset]

  • Sancho‐Albero, María
  • Martín-Pardillos, Ana
  • Irusta, Silvia
  • Sebastián, Víctor
  • Cebolla, Vicente L.
  • Pazo-Cid, Roberto
  • Martín-Duque, Pilar
  • Santamaría, Jesús
The study was conducted in accordance with the Declaration of Helsinki, and approved by the Human Research Review Committee of the Research Ethics Committee of the Community of Aragon (Comité de Ética de la Investigación de la Comunidad de Aragón, CEICA) ((PI18/198), 04/07/2018).-- Licensed under the terms and conditions of the Creative Commons Attribution (CC BY) license., Table S1: Atomic percentage of EVs isolated from cell cultures. Mean ± SD; Table S2: Nitrogen chemical environmental analysis of EVs isolated from cell cultures. Mean ± SD; Table S3: Percentage atomic composition of EVs isolated from female control donors (n = 6) and ovarian tumor patients of different tumor grades: I (n = 8), II (n = 1), III (n = 2) and IV (n = 7). Mean ± SD; Table S4: Nitrogen composition of EVs isolated from female control donors (n = 6) and ovarian tumor patients of different tumor grades: I (n = 8), II (n = 1), III (n = 2) and IV (n = 7). Mean ± SD; Table S5: Atomic composition of EVs isolated from healthy donors (n = 10) and pancreatic tumor patients (n = 10) at diagnosis. Mean ± SD; Table S6: Nitrogen composition of EVs isolated from healthy donors (n = 10) and pancreatic tumor patients (n = 10) at diagnosis. Mean ± SD., This research was funded by ERC Advanced Grant CADENCE, grant number ERC-2016-ADG-742684”. The research was supported by Instituto de Salud Carlos III (ISCIII) (PI19/01007 and DTS21/00130) and by Fondo Europeo de Desarrollo Regional (Feder) “Una manera de hacer Europa”. We also thank CIBER-BBN, an initiative funded by the VI National R&D&i Plan 2008–2011 financed by the Instituto de Salud Carlos III (ISCIII) with the assistance of the European Regional Development Fund. This study was also partially funded by the Aragon Government (Ph.D. Grant No.r B054/12) and co-funded by Aragon/FEDER 2014–2020 “Building Europe from Aragon”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Kidney microRNA Expression Pattern in Type 2 Diabetic Nephropathy in BTBR Ob/Ob Mice

  • Opazo-Ríos, Lucas
  • Tejera-Muñoz, Antonio
  • Soto Catalan, Manuel
  • Marchant, Vanessa
  • Mas Fontao, Sebastián
  • Lavoz, Carolina
  • Moreno, Juan Antonio
  • Fierro Fernandez, Marta
  • Ramos, Ricardo
  • Suarez-Alvarez, Beatriz
  • López-Larrea, Carlos
  • Ruiz-Ortega, Marta
  • Egido, Jesús
  • Rodrigues-Díez, Raúl R.
Diabetic nephropathy (DN) is the main leading cause of chronic kidney disease worldwide. Although remarkable therapeutic advances have been made during the last few years, there still exists a high residual risk of disease progression to end-stage renal failure. To further understand the pathogenesis of tissue injury in this disease, by means of the Next-Generation Sequencing, we have studied the microRNA (miRNA) differential expression pattern in kidneys of Black and Tan Brachyury (BTBR) ob/ob (leptin deficiency mutation) mouse. This experimental model of type 2 diabetes and obesity recapitulates the key histopathological features described in advanced human DN and therefore can provide potential useful translational information. The miRNA-seq analysis, performed in the renal cortex of 22-week-old BTBR ob/ob mice, pointed out a set of 99 miRNAs significantly increased compared to non-diabetic, non-obese control mice of the same age, whereas no miRNAs were significantly decreased. Among them, miR-802, miR-34a, miR-132, miR-101a, and mir-379 were the most upregulated ones in diabetic kidneys. The in silico prediction of potential targets for the 99 miRNAs highlighted inflammatory and immune processes, as the most relevant pathways, emphasizing the importance of inflammation in the pathogenesis of kidney damage associated to diabetes. Other identified top canonical pathways were adipogenesis (related with ectopic fatty accumulation), necroptosis (an inflammatory and regulated form of cell death), and epithelial-to-mesenchymal transition, the latter supporting the importance of tubular cell phenotype changes in the pathogenesis of DN. These findings could facilitate a better understanding of this complex disease and potentially open new avenues for the design of novel therapeutic approaches to DN., This work was supported by grants from the Instituto de Salud Carlos III (ISCIII) and Fondos FEDER European Union (PI17/ 00119, PI17/01495, PI17/00130, PI20/00140, PI19/00184, PI20/00639, PI20/00487, PI20/00375, DTS20/00083, and DTS19/00093), Red de Investigación Renal REDINREN: RD16/0009 to MR-O (RD16/0009/0003) and to CL-L (RD16/0009/0020), Sociedad Española de Nefrología, “NOVELREN-CM: Enfermedad renal crónica: nuevas Estrategias para la prevención, Diagnóstico y tratamiento” (B2017/BMD-3751 to MR-O), “Convocatoria Dinamización Europa Investigación 2019” MINECO (EIN 2019-103294 to MR-O), Innovation programme under the Marie SkłodowskaCurie grant of the European Union’s Horizon 2020 (IMProve-PD ID: 812699 to MR-O), Spanish Biomedical Research Centre in Cardiovascular Diseases (CIBERCV), Spanish Ministry of Science and Innovation (RYC-2017- 22369), Consejería de Salud y Familias-FEDER, Junta de Andalucía (PIGE-0052-2020 to JM), and Gobierno de Chile (S-2020-05 VIDCA-UACh to CL). RICORS program to RICORS2040 (KIDNEY DISEASE) RD21/0005/0002 to MRO; RD21/0005/0017 to CL-L.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Klebsiella pneumoniae survives within macrophages by avoiding delivery to lysosomes

  • Cano, V.
  • March, C.
  • Insua, J.L.
  • Aguiló, N.
  • Llobet, E.
  • Moranta, D.
  • Regueiro, V.
  • Brennan, G.P.
  • Millán-Lou, M.I.
  • Martín, C.
  • Garmendia, J.
  • Bengoechea, J.A.
Klebsiella pneumoniae is an important cause of community-acquired and nosocomial pneumonia. Evidence indicates that Klebsiella might be able to persist intracellularly within a vacuolar compartment. This study was designed to investigate the interaction between Klebsiella and macrophages. Engulfment of K.pneumoniae was dependent on host cytoskeleton, cell plasma membrane lipid rafts and the activation of phosphoinositide 3-kinase (PI3K). Microscopy studies revealed that K.pneumoniae resides within a vacuolar compartment, the Klebsiella-containing vacuole (KCV), which traffics within vacuoles associated with the endocytic pathway. In contrast to UV-killed bacteria, the majority of live bacteria did not co-localize with markers of the lysosomal compartment. Our data suggest that K.pneumoniae triggers a programmed cell death in macrophages displaying features of apoptosis. Our efforts to identify the mechanism(s) whereby K.pneumoniae prevents the fusion of the lysosomes to the KCV uncovered the central role of the PI3K-Akt-Rab14 axis to control the phagosome maturation. Our data revealed that the capsule is dispensable for Klebsiella intracellular survival if bacteria were not opsonized. Furthermore, the environment found by Klebsiella within the KCV triggered the down-regulation of the expression of cps. Altogether, this study proves evidence that K.pneumoniae survives killing by macrophages by manipulating phagosome maturation that may contribute to Klebsiella pathogenesis. Prevailing belief states that the human pathogens Klebsiella pneumoniae is an extracellular pathogen. However, in this work, we demonstrate that K. pneumoniae co-opts the maturation of the phagosome manipulating a PI3K-AKT-RAB14 signalling cascade. Here, we also demonstrate that by preventing the activation of this cascade, the macrophages eliminate intracellular Klebsiella.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Maternal proteomic profiling reveals alterations in lipid metabolism in late-onset fetal growth restriction

  • Paules, C.
  • Youssef, L.
  • Miranda, J.
  • Crovetto, F.
  • Estanyol, J.M.
  • Fernandez, G.
  • Crispi, F.
  • Gratacós, E.
Fetal growth restriction defined as the failure to achieve the fetal genetic growth potential is a major cause of perinatal morbidity and mortality. The role of maternal adaptations to placental insufficiency in this disorder is still not fully understood. We aimed to investigate the biological processes and protein–protein interactions involved in late-onset fetal growth restriction in particular. We applied 2D nano LC–MS/MS proteomics analysis on maternal blood samples collected at the time of delivery from 5 singleton pregnancies with late-onset fetal growth restriction and 5 uncomplicated pregnancies. Data were analyzed using R package “limma” and Ingenuity Pathway Analysis. 25 proteins showed significant changes in their relative abundance in late-onset fetal growth restriction (p value < 0.05). Direct protein–protein interactions network demonstrated that Neurogenic locus notch homolog protein 1 (NOTCH1) was the most significant putative upstream regulator of the observed profile. Gene ontology analysis of these proteins revealed the involvement of 14 canonical pathways. The most significant biological processes were efflux of cholesterol, efflux of phospholipids, adhesion of blood cells, fatty acid metabolism and dyslipidemia. Future studies are warranted to validate the potential role of the detected altered proteins as potential therapeutic targets in the late-onset form of fetal growth restriction.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Integrating Dietary Data into Microbiome Studies: A Step Forward for Nutri-Metaomics

  • Yañez Araya, Francisca
  • Soler Luque, Zaida
  • Oliero, Manon
  • Oyarzun Lafuente, Iñigo
  • Serrano Gomez, Gerard
  • Manichanh, Chaysavanh
  • Xie, Zixuan
Relación dieta-microbioma; Validación relativa; Desarrollo de sFFQ, Relació dieta-microbioma; Validació relativa; Desenvolupament sFFQ, Diet–microbiome relationship; Relative validation; sFFQ development, Diet is recognised as the main driver of changes in gut microbiota. However, linking habitual dietary intake to microbiome composition and activity remains a challenge, leaving most microbiome studies with little or no dietary information. To fill this knowledge gap, we conducted two consecutive studies (n = 84: a first pilot study (n = 40) to build a web-based, semi-quantitative simplified FFQ (sFFQ) based on three 24-h dietary recalls (24HRs); a second study (n = 44) served to validate the newly developed sFFQ using three 24HRs as reference method and to relate gut microbiome profiling (16S rRNA gene) with the extracted dietary and lifestyle data. Relative validation analysis provided acceptable classification and agreement for 13 out of 24 (54%) food groups and 20 out of 29 nutrients (69%) based on intraclass correlation coefficient, cross-classification, Spearman’s correlation, Wilcoxon test, and Bland–Altman. Microbiome analysis showed that higher diversity was positively associated with age, vaginal birth, and intake of fruit. In contrast, microbial diversity was negatively associated with BMI, processed meats, ready-to-eat meals, sodium, and saturated fat. Our analysis also revealed a correlation between food groups or nutrients and microbial composition. Overall, we provide the first dietary assessment tool to be validated and correlated with microbiome data for population studies., This study was supported by grants from by the Instituto de Salud Carlos III/FEDER (PI17/00614; PI20/00130), a government agency. Francisca Yáñez was supported by a fellowship from ANID, BECAS Chile, No. 72190278. Zixuan Xie received a fellowship from the European Union’s Horizon 2020 research and innovation program under the Marie Sklodowska-Curie Action, Innovative Training Network: FunHoMic; grant number 812969.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Patient-derived preclinical models to develop immunotherapies

  • Seoane, Joan
Immuno-oncology; Preclinical models; Tumor microenvironment, Inmuno-oncología; Modelos preclínicos; Microambiente tumoral, Immuno-oncologia; Models preclínics; Microambient tumoral, Cancer immunotherapy has revolutionized the treatment of some malignancies. Yet, many tumors do not unfortunately respond to immune-based therapies. Deeper insights into the biology of the immune response to cancer are required to identify novel therapeutic targets and advance immuno-oncology. To do so, we need to study cancer in patient-derived models that can faithfully recapitulate and capture the complexity and heterogeneity of the tumor immune ecosystem. Platforms facilitating the analysis of the human tumor immune microenvironment of individual patients are crucial. Patient-derived models are fundamental not only to better understand the biology of the cancer immune system but also to discern the mechanism of action of therapeutic compounds and perform preclinical studies toward improving the success of subsequent clinical testing. In this viewpoint, I present a brief review of patient-derived models for cancer immunotherapy., Fundación Asociación Española Contra el Cáncer (AECC). Cellex Foundation. BBVA (CAIMI). ISCIII FIS. Grant Number: PI22 00130
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Chemical markers to distinguish the homoand heterozygous bitter genotype in sweet almond kernels

  • Vichi, Stefania
  • Mayer, Morgana N.
  • León-Cárdenas, Maria G.
  • Quintanilla-Casas, Beatriz
  • Tres, Alba
  • Guardiola, Francesc
  • Batlle, Ignasi
  • Romero, Agustí
Bitterness in almonds is controlled by a single gene (Sk dominant for sweet kernel, sk recessive for bitter kernel) and the proportions of the offspring genotypes (SkSk, Sksk, sksk) depend on the progenitors’ genotype. Currently, the latter is deduced after crossing by recording the phenotype of their descendants through kernel tasting. Chemical markers to early identify parental genotypes related to bitter traits can significantly enhance the efficiency of almond breeding programs. On this basis, volatile metabolites related to almond bitterness were investigated by Solid Phase Microextraction-Gas Chromatography-Mass Spectrometry coupled to univariate and multivariate statistics on 244 homo- and heterozygous samples from 42 different cultivars. This study evidenced the association between sweet almonds’ genotype and some volatile metabolites, in particular benzaldehyde, and provided for the first time chemical markers to discriminate between homo- and heterozygous sweet almond genotypes. Furthermore, a multivariate approach based on independent variables was developed to increase the reliability of almond classification. The Partial Least Square-Discriminant Analysis classification model built with selected volatile metabolites that showed discrimination capacity allowed a 98.0% correct classification. The metabolites identified, in particular benzaldehyde, become suitable markers for the early genotype identification in almonds, while a DNA molecular marker is not yet available., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

GSR-DB: a manually curated and optimized taxonomical database for 16S rRNA amplicon analysis

  • González Molano, Leidy Alejandra
  • Vega Abellaneda, Sara
  • Chaysavanh, Manichanh
Database; Microbiome; Taxonomy, Base de datos; Microbioma; Taxonomía, Base de dades; Microbioma; Taxonomia, Amplicon-based 16S ribosomal RNA sequencing remains a widely used method to profile microbial communities, especially in low biomass samples, due to its cost-effectiveness and low-complexity approach. Reference databases are a mainstay for taxonomic assignments, which typically rely on popular databases such as SILVA, Greengenes, Genome Taxonomy Database (GTDB), or Ribosomal Database Project (RDP). However, the inconsistency of the nomenclature across databases and the presence of shortcomings in the annotation of these databases are limiting the resolution of the analysis. To overcome these limitations, we created the GSR database (Greengenes, SILVA, and RDP database), an integrated and manually curated database for bacterial and archaeal 16S amplicon taxonomy analysis. Unlike previous integration approaches, this database creation pipeline includes a taxonomy unification step to ensure consistency in taxonomical annotations. The database was validated with three mock communities, two real data sets, and a 10-fold cross-validation method and compared with existing 16S databases such as Greengenes, Greengenes 2, GTDB, ITGDB, SILVA, RDP, and MetaSquare. Results showed that the GSR database enhances taxonomical annotations of 16S sequences, outperforming current 16S databases at the species level, based on the evaluation of the mock communities. This was confirmed by the 10-fold cross-validation, except for Greengenes 2. The GSR database is available for full-length 16S sequences and the most commonly used hypervariable regions: V4, V1–V3, V3–V4, and V3–V5. IMPORTANCE Taxonomic assignments of microorganisms have long been hindered by inconsistent nomenclature and annotation issues in existing databases like SILVA, Greengenes, Greengenes2, Genome Taxonomy Database, or Ribosomal Database Project. To overcome these issues, we created Greengenes-SILVA-RDP database (GSR-DB), accurate and comprehensive taxonomic annotations of 16S amplicon data. Unlike previous approaches, our innovative pipeline includes a unique taxonomy unification step, ensuring consistent and reliable annotations. Our evaluation analyses showed that GSR-DB outperforms existing databases in providing species-level resolution, especially based on mock-community analysis, making it a game-changer for microbiome studies. Moreover, GSR-DB is designed to be accessible to researchers with limited computational resources, making it a powerful tool for scientists across the board. Available for full-length 16S sequences and commonly used hypervariable regions, including V4, V1–V3, V3–V4, and V3–V5, GSR-DB is a go-to database for robust and accurate microbial taxonomy analysis., This work was supported by the Instituto de Salud Carlos III/FEDER (PI20/00130). Funding for open access charge was provided by Instituto de Salud Carlos III/FEDER.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Distinct microbial mediators link diet to inflammation in Crohn’s disease and ulcerative colitis

  • Campderros, Laura
  • Pons Tarín, Marc
  • Mayorga Ayala, Luis Fernando
  • Noguera Segura, Arnau
  • Soler, Zaida
  • Vega Abellaneda, Sara
  • Serrano Gómez, Gerard
  • Herrera-deGuise, Claudia
  • robles, virginia
  • BORRUEL, NATALIA
  • Chaysavanh, Manichanh
Crohn's disease; Ulcerative colitis, Enfermedad de Crohn; Colitis ulcerosa, Malaltia de Crohn; Colitis ulcerosa, Background Inflammatory bowel disease (IBD) arises from complex interactions among diet, host and gut microbiome. Although diet influences intestinal inflammation, the microbial and metabolic pathways involved, and their differences between Crohn’s disease (CD) and ulcerative colitis (UC), the two main subtypes of IBD remain unclear. Objective To investigate how the gut microbiome mediates the effects of habitual diet on inflammatory activity in IBD. Design This longitudinal study included 198 adults (100 healthy controls, 49 CD, 49 UC), participants completed a validated food frequency questionnaire. Dietary quality was evaluated using established indices (Alternative Mediterranean Diet, Healthy Eating Index-2015, Índice de Alimentación Saludable, Mean Adequacy Ratio, Plant-Based Dietary Indexes, Healthy Food Diversity). Participants also provided two stool samples (baseline and 6 months). Shotgun metagenomics (n=366) enabled taxonomic and functional profiling. Causal mediation analyses were used to identify microbial features mediating the effect of diet on inflammation. Results IBD patients exhibited lower dietary diversity, fibre intake and nutritional adequacy compared with controls. Microbiome diversity was lowest in CD, intermediate in UC and correlated positively with higher intake of fibre, fruit, vegetables and nuts, and negative with processed foods and sugary beverages. Causal mediation analyses revealed that in CD, coffee, whole wheat bread and healthier diets lowered the Harvey-Bradshaw index through specific bacterial species and metabolites. In UC, Mediterranean-like diets, fruits and coffee reduced C reactive protein via greater microbial richness, reduced dysbiosis and short-chain fatty acid-related functions. Conclusion Diet quality influences inflammation in IBD through distinct microbiome pathways: specific taxa and metabolites mediate effects in CD, whereas microbial richness and global composition drive protection in UC. Data availability statement Data are available upon reasonable request. The data generated in this study are available within this manuscript and its Supplementary Information. Analytic methods, study materials and sequencing data will be made available by the corresponding author upon reasonable request. Due to patient confidentiality, the metadata are available upon reasonable request., This work was financially supported by Spanish institutions: the Instituto de Salud Carlos III and co-funded by the European Union (ERDF/ESF, 'A way to make Europe'/'Investing in your future' (PI20/00130), the Ministry of Economy and Competitiveness (MINECO), with co-funding from FEDER (E.U.) (PID23-147387OB-100) and the AGAUR (2021 SGR 00459). None of the funders were private companies.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

The Effect of Probiotics on Preterm Birth Rates in Pregnant Women After a Threatened Preterm Birth Episode (The PROPEV Trial)

  • Miserachs Sala, Marta
  • Puerto Tamayo , Linda Grace
  • Garrido-Giménez, Carmen
  • Soler, Zaida
  • Dalmau Artal, Marta
  • Casellas de Miguel, Alba
  • Carreras, Elena
  • Goya, Maria
  • del Barco Martínez, Ester
  • González Molano, Leidy Alejandra
  • VARGAS BUJÁN, MIREIA
  • Chaysavanh, Manichanh
Microbiota; Preterm birth; Probiotics, Microbiota; Parto prematuro; Probióticos, Microbiota; Part prematur; Probiòtics, Introduction: Preterm birth is the leading cause of perinatal mortality worldwide, with prevalence rates showing little reduction. Although mortality rates have decreased, morbidity rates remain concerningly high. In recent years, there has been a surge in studies examining the etiology, risk factors, and management of preterm birth. The use of vaginal probiotics in pregnant women at risk of preterm birth has garnered attention as a potential approach for improving perinatal outcomes and modulating the vaginal microbiota. However, the efficacy of this intervention remains unclear. Therefore, this study explored the impact of vaginal probiotics on perinatal outcomes and vaginal microbiota composition in pregnant women at risk of preterm birth. Materials and Methods: This was a randomized, prospective, longitudinal, double-blind, placebo-controlled, multicentric trial conducted across seven maternities in Spain from October 2017 to August 2022 in pregnant women at risk of preterm birth. Participants were randomly assigned to receive vaginal probiotics containing four lactobacilli strains or a placebo. The primary outcome was to explore a potential correlation between probiotic use among pregnant women at risk of preterm birth and the actual rate of preterm birth before 37 gestational weeks. Secondary outcomes included an evaluation of preterm birth rates, neonatal morbidity, the vaginal microbiota, and changes in the vaginal microbiota after receiving probiotics. Other secondary outcomes were identifying vaginal microbiota patterns associated with preterm birth and exploring potential therapeutic mechanisms involving probiotics. Trial registration: Clinicaltrials.gov, identifier: NCT03689166. Results: A total of 200 participants were included. Of those, birth data were obtained for 181 women. Demographics were similar between both groups. An analysis of perinatal outcomes found no significant differences in preterm birth rates, prematurity rates, gestational weeks at delivery, neonatal complications, time to birth, or latency time to delivery. Microbiota analysis showed no significant differences in vaginal microbiota changes between groups. No serious or unexpected adverse reactions were reported. Conclusions: There were no statistically significant differences for spontaneous preterm birth between pregnant women receiving probiotics and pregnant women receiving the placebo., This work was supported by the Spanish Clinical Research Network (SCReN), which is funded by the ISCIII-General Subdirectorate for Evaluation and Promotion of Research through projects PT17/0017/0030 and PT20/00078. Both projects were integrated into the 2013–2016 National Plan for Scientific and Technical Research and Innovation and co-financed by the European Regional Development Fund (ERDF), “A way of making Europe”. This work was also supported by Project FIS PI 19/00287 (Maria Goya as a principal investigator), which was funded by Instituto de Salud Carlos III (ISCIII) and co-funded by the European Union. Laboratorios Ordesa S.L funded the PROPEV study. L.-A.G.M. was supported by Instituto de Salud Carlos III/FEDER (PI20/00130).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

El programa de mejora genética de almendro del IRTA: 50 años de actividad (1974-2024)

  • Batlle, Ignasi
  • Calle, Alejandro
  • Vargas, F.J.
En 1974, se inició el programa de mejora genética de almendro del IRTA con el propósito de mejorar la calidad del material vegetal disponible. Durante estos 50 años de actividad, los objetivos han sido la obtención de variedades con características, como floración tardía, autocompatibilidad, alta productividad, calidad del fruto, facilidad de formación y poda, vigor adecuado y resistencia a enfermedades. A lo largo del programa se han realizado 1.226 cruzamientos, polinizado 803.587 flores y evaluado 74.025 seedlings. Como resultado, se han introducido en el mercado siete variedades ('Masbovera', 'Glorieta’, 'Francoli’, 'Vairo', 'Constanti', 'Tarraco' y 'Marinada') y un portainjerto híbrido almendro x melocotonero de bajo vigor ('Intensia') para plantaciones intensivas. Asimismo, varias selecciones avanzadas están en fase final de evaluación. En la última década, el programa también se dedica a mejorar y resintetizar 'Marcona', con el objetivo de obtener una variedad genéticamente similar de floración tardía y autocompatible., El programa de mejora del IRTA se ha financiado fundamentalmente a través proyectos nacionales e internacionales. Los nacionales han sido: SC97-049, RTA01-081, RTA04-030, RTA07-057, TRT2006 -00021-00-00, RTA2011-00130-00- 00, AGL2013-48577-C2-2-R, RTA2017-00084-00-00, PID2020-114648RR-C31, PDC2021-121639-100. El programa de mejora ha contado con la participación técnica de S. Alegre; N.Aletà; P.Arús; J.Clavé; I.Eduardo; L.W. Howard; L. Lipan; M.López; X. Miarnau; M.Mnejja; A.Ninot; F. Pérez de los Cobos; M.A. Romero; A. Romero; M. Rovira; J. Santos; L.Torguet. Respecto al equipo de soporte, el programa ha contado con la participación de L.Abelló, M. Domènech; J. Ma. Fargas; J. Ma. Ferré; J.F. Hermoso; J. Ma. Gener, R. Girabet; R. Magrinyà; E. Martí; J. Pàmies; S.Tost y J. Vergès., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

FunOMIC: Pipeline with built-in fungal taxonomic and functional databases for human mycobiome profiling

  • Manichanh, Chaysavanh
  • Xie, Zixuan
Fungal databases; Taxonomy and functions; Inter-kingdom interactions, Bases de datos de hongos; Taxonomía y funciones; Interacciones entre reinos, Bases de dades de fongs; Taxonomia i funcions; Interaccions entre regnes, While analysis of the bacterial microbiome has become routine, that of the fungal microbiome is still hampered by the lack of robust databases and bioinformatic pipelines. Here, we present FunOMIC, a pipeline with built-in taxonomic (1.6 million marker genes) and functional (3.4 million non-redundant fungal proteins) databases for the identification of fungi. Applied to more than 2,600 human metagenomic samples, the tool revealed fungal species associated with geography, body sites, and diseases. Correlation network analysis provided new insights into inter-kingdom interactions. With this pipeline and two of the most comprehensive fungal databases, we foresee a fast-growing resource for mycobiome studies., This work was supported by the European Union’s Horizon 2020 research and innovation program under the Marie Sklodowska-Curie Action, Innovative Training Network [grant number 812969] and by the Instituto de Salud Carlos III /FEDER, a government agency (Grant No: PI17/00614; PI20/00130).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Microbiome multi-omics analysis reveals novel biomarkers and mechanisms linked with CD etiopathology

  • Soler Luque, Zaida
  • Pons Tarín, Marc
  • Mayorga Ayala, Luis Fernando
  • Consegal, Marta
  • Manjon, Isaac
  • Serrano Gómez, Gerard
  • Yañez, Francisca
  • Herrera-deGuise, Claudia
  • BORRUEL, NATALIA
  • Rodriguez-Sinovas, Antonio
  • Vega Abellaneda, Sara
  • Chaysavanh, Manichanh
Inflammatory bowel disease; Microbiome; Multi-omics, Enfermedad inflamatoria intestinal; Microbioma; Multiómica, Malaltia inflamatòria intestinal; Microbioma; Multiòmica, Background The gut microbiome plays a key role in the development of inflammatory bowel disease (IBD), as imbalances in microbial composition are associated with immune dysfunction. However, the specific mechanisms by which certain microorganisms contribute to this process remain unclear. Methods Here, we employed a multi-omics approach on fecal samples to identify novel microbiome markers and elucidate mechanisms underlying IBD. Shotgun metagenomics was applied to 212 samples (850 in total with validation cohort), shotgun metatranscriptomics to 103 samples and metabolomics to 105 samples. Machine learning techniques were used to predict disease and the three omics data were integrated to propose a mechanistic role of the microbiota. Results Metagenomic analysis identified Crohn's disease (CD)-specific microbiome signatures, including a panel of 20 species that achieved a high diagnostic performance, with an area under the ROC curve (AUC) of 0.94 in an external validation set. Metatranscriptomic analysis revealed significant alterations in microbial fermentation pathways in CD, but not in ulcerative colitis (UC), highlighting disruptions that explain the depletion of butyrate—a key anti-inflammatory metabolite—observed in metabolomics analysis. Integrative multi-omics analyses further identified active virulence factor genes in CD, predominantly originating from the adherent-invasive Escherichia coli (AIEC). Notably, these findings unveiled novel mechanisms, including E. coli-mediated aspartate depletion and the utilization of propionate, which drives the expression of the ompA virulence gene, critical for bacterial adherence and invasion of the host’s macrophages. Interestingly, these microbiome alterations were absent in UC, underscoring distinct mechanisms of disease development between the two IBD subtypes. Conclusions In conclusion, our study not only identifies promising novel biomarkers with strong diagnostic potential, which could be valuable in challenging clinical scenarios, but also offers an integrated multi-omics perspective on the microbial mechanisms underlying inflammation and virulence in Crohn's disease., This work was supported by the Instituto de Salud Carlos III/FEDER (PI20/00130; FI21/00262). Marc Pons and Sara Vega-Abellaneda were supported by the AGAUR (2021 SGR 00459). Francisca Yáñez was supported by a fellowship from ANID, BECAS Chile, No. 72190278.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Targeting the Warburg Effect in Cancer: Where Do We Stand?

  • Carrillo-Bosch, Laura
  • Barba, Ignasi
  • Seoane, Joan
Warburg effect; Aerobic glycolysis; Tumor metabolism, Efecto Warburg; Glucólisis aeróbica; Metabolismo tumoral, Efecte Warburg; Glucòlisi aeròbica; Metabolisme tumoral, The Warburg effect, characterized by the preferential conversion of glucose to lactate even in the presence of oxygen and functional mitochondria, is a prominent metabolic hallmark of cancer cells and has emerged as a promising therapeutic target for cancer therapy. Elevated lactate levels and acidic pH within the tumor microenvironment (TME) resulting from glycolytic profoundly impact various cellular populations, including macrophage reprogramming and impairment of T-cell functionality. Altogether, the Warburg effect has been shown to promote tumor progression and immunosuppression through multiple mechanisms. This review provides an overview of the current understanding of the Warburg effect in cancer and its implications. We summarize recent pharmacological strategies aimed at targeting glycolytic enzymes, highlighting the challenges encountered in achieving therapeutic efficacy. Additionally, we examine the utility of the Warburg effect as an early diagnostic tool. Finally, we discuss the multifaceted roles of lactate within the TME, emphasizing its potential as a therapeutic target to disrupt metabolic interactions between tumor and immune cells, thereby enhancing anti-tumor immunity., The study was undertaken with the support of the Fundación Asociación Española contra el Cáncer (AECC), the ISCIII, FIS (PI22/00130), BBVA (CAIMI), and Cellex Foundation.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Metabolic, mitochondrial, renal and hepatic safety of enfuvirtide and raltegravir antiretroviral administration, Randomized crossover clinical trial in healthy volunteers

  • Barroso, Sergio|||0000-0001-7504-4794
  • Morén, Constanza|||0000-0001-6848-7407
  • González-Segura, Àlex|||0000-0002-9398-2183
  • Riba, Neus
  • Arnaiz, Joan Albert
  • Manríquez, Marcela
  • Santana, Gemina
  • Blanco Arévalo, José Luis|||0000-0003-2010-2744
  • Larousse, María
  • Loncà, Montse
  • de Lazzari, Elisa|||0000-0003-2614-6545
  • Llopis, Jaume
  • Mallolas Masferrer, Josep|||0000-0002-8365-141X
  • Miró, Oscar|||0000-0002-7924-9751
  • Carné, Xavier
  • Gatell, José Mª|||0000-0002-4705-3244
  • Garrabou, Glòria|||0000-0001-8973-9933
  • Martínez, Esteban|||0000-0002-6911-8846
Context Classical antiretroviral agents may acutely impact on metabolic, mitochondrial, renal and hepatic function in HIV-infected and uninfected persons. Fusion and integrase inhibitors are supposed to be safer, but have been scarcely investigated. To avoid any interference with HIV or other antiretrovirals, we assessed markers of these toxicities in healthy adult volunteers treated with Enfuvirtide (T20) or Raltegravir (RAL). Methods Twenty-six healthy participants were randomized to T20/90mg vs. placebo (n = 12) or RAL/ 400mg vs. placebo (n = 14) every 12h in two 7-day periods separated by a 4-week washout period. Major end-points were changes in lipid profile (total cholesterol, high-density-lipoprotein (HDL)-cholesterol, low-density-lipoprotein (LDL)-cholesterol, triglycerides), insulin resistance (glucose) and mitochondrial toxicity (mitochondrial DNA content-mtDNA-in peripheral blood mononuclear cells). Renal and hepatic toxicity (creatinine, alanine transaminase (AST), alanine aminotransferase (ALT), bilirubin and total plasma proteins) and overall safety were also analysed. Effect of period, treatment, and basal measures were evaluated for each end-point. Results Neither T20-administration nor RAL-administration yielded to any statistic significant change in the markers of metabolic, mitochondrial, renal or hepatic toxicity assessed. No symptoms indicative of drug toxicity were neither found in any subject. Conclusions In absence of HIV infection, or concomitant treatment, short-term exposure to T20 or RAL in healthy adult volunteers did not lead to any indicative changes in toxicity markers thus presuming the safe profile of both drugs.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

EuroQol (EQ-5D-5L) Validity in Assessing the Quality of Life in Adults With Asthma, Cross-Sectional Study

  • Hernandez, Gimena|||0000-0001-5319-3465
  • Garin, Olatz|||0000-0001-6193-0779
  • Dima, Alexandra Lelia|||0000-0002-3106-2242
  • Pont, Angels|||0000-0002-0602-552X
  • Martí Pastor, Marc|||0000-0001-6189-2178
  • Alonso, Jordi|||0000-0001-8627-9636
  • Van Ganse, Eric|||0000-0002-7463-9187
  • Laforest, Laurent|||0000-0002-3694-7699
  • de Bruin, Marijn|||0000-0003-3100-6803
  • Mayoral, K.|||0000-0002-7904-4422
  • Serra Sutton, Vicky|||0000-0002-7852-175X
  • Ferrer Forés, Maria Montserrat|||0000-0001-9867-7391
The EuroQol-5 Dimension (EQ-5D), developed in 1990, is a most widely used generic tool to measure the health-related quality of life (HRQoL) and considered suitable for patients with asthma. In 2009, the EuroQol Group developed a new EQ-5D version to overcome limitations related to its consistently reported high ceiling effect. To enhance the sensitivity for assessing the HRQoL in further patient populations, the number of responses of EQ-5D was increased from 3 to 5 levels (EQ-5D-5L). Moreover, the availability of well-defined requirements for its Web-based administration allows EQ-5D-5L use to monitor the HRQoL in electronic health (eHealth) programs. No study has evaluated the metric properties of the new EQ-5D-5L in patients with asthma yet. This study aims to examine the distribution, construct validity, and reliability of the new EQ-5D-5L questionnaire administered online to adults with asthma. We evaluated patients with asthma (age: 18-40 years) from a primary care setting in France and England, who self-completed the EQ-5D-5L questionnaire online. The inclusion criteria were persistent asthma defined as.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Head-to-head comparison between the EQ-5D-5L and the EQ-5D-3L in general population health surveys

  • Martí Pastor, Marc|||0000-0001-6189-2178
  • Pont, Angels|||0000-0002-0602-552X
  • Ávila, Mónica|||0000-0001-9583-5104
  • Garin, Olatz|||0000-0001-6193-0779
  • Vilagut, Gemma|||0000-0002-3714-226X
  • Forero, Carlos G.|||0000-0002-5245-0076
  • Pardo Cladellas, Yolanda|||0000-0003-4982-5495
  • Tresserras, Ricard
  • Medina-Bustos, Antonia
  • Garcia-Codina, Oriol
  • Cabasés, Juan
  • Rajmil, Luis|||0000-0002-6625-0649
  • Alonso, Jordi|||0000-0001-8627-9636
  • Ferrer Forés, Maria Montserrat|||0000-0001-9867-7391
The EQ-5D has been frequently used in national health surveys. This study is a head-to-head comparison to assess how expanding the number of levels from three (EQ-5D-3L) to five in the new EQ-5D-5L version has improved its distribution, discriminatory power, and validity in the general population. A representative sample (N = 7554) from the Catalan Health Interview Survey 2011-2012, aged ≥18, answered both EQ-5D versions, and we evaluated the response redistribution and inconsistencies between them. To assess validity of this redistribution, we calculated the mean of the Visual Analogue Scale (VAS), which measures perceived health. The discriminatory power was examined with Shannon Indices, calculated for each dimension separately. Spanish preference value sets were applied to obtain utility indices, examining their distribution with statistics of central tendency and dispersion. We estimated the proportion of individuals reporting the best health state in EQ-5D-5L and EQ-5D-3L within groups of specific chronic conditions and their VAS mean. A very small reduction in the percentage of individuals with the best health state was observed, from 61.8% in EQ-5D-3L to 60.8% in EQ-5D-5L. In contrast, a large proportion of individuals reporting extreme problems in the 3 L version moved to severe problems (level 4) in the 5 L version, particularly for pain/discomfort (75.5%) and anxiety/depression (66.4%). The average proportion of inconsistencies was 0.9%. The pattern of the perceived health VAS mean confirmed the hypothesis established a priori, supporting the validity of the observed redistribution. Shannon index showed that absolute informativity was higher in the 5 L version for all dimensions. The means (SD) of the Spanish EQ-5D-3L and EQ-5D-5L indices were 0.87 (0.25) and 0.89 (0.22). The proportion of individuals with the best health state within each specific chronic condition was very similar, regardless of the EQ-5D version (≤ 30% in half of the 28 chronic conditions). Although the proportion of individuals with the best possible health state is still very high, our findings support that the increase of levels provided by the EQ-5D-5L contributed to the validity and discriminatory power of this new version to measure health in general population, as in the national health surveys. The online version of this article (10.1186/s12963-018-0170-8) contains supplementary material, which is available to authorized users.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Podocyte and tubular involvement in AngioJet-induced kidney injury

  • Esteras, Raquel
  • Cannata-Ortiz, Pablo
  • del Palacio-Tamarit, Marta
  • Guerrero-Hue, Melania
  • García-Caballero, Cristina
  • Egido, Jesús
  • Gimeno Beltran, Javier|||0000-0001-6085-5228
  • Ortiz, Alberto|||0000-0002-9805-9523
  • Gracia-Iguacel, Carolina
  • Moreno Gutiérrez, Juan Antonio|||0000-0002-7468-2871
The AngioJet technique combines localized thrombolysis and percutaneous mechanical thrombectomy (PMT). However, PMT may cause acute kidney injury (AKI), which has been ascribed to severe mechanical haemolysis, although no renal biopsies have been reported. We now report the first renal biopsy in a patient with AKI following PMT. There is histological evidence of haemoglobin (Hb)-induced tubular injury and podocyte stress characterized by intracellular Hb and staining for ferritin and hemo-oxygenase-1, suggestive of an adaptive response to oxidative stress. This confirms that Hb is involved in kidney cell injury and supports the existence of several different kidney cellular targets.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Dysbiosis and relapse-related microbiome in inflammatory bowel disease, a shotgun metagenomic approach

  • Serrano-Gómez, Gerard|||0000-0002-9447-3778
  • Mayorga, Luis
  • Oyarzun, Iñigo
  • Roca, Joaquim
  • Borruel, Natalia|||0000-0002-4449-2292
  • Casellas, Francesc|||0000-0003-3196-039X
  • Varela, Encarna|||0000-0001-6334-9320
  • Pozuelo, Marta|||0000-0001-8357-1172
  • Machiels, Kathleen
  • Guarner, Francisco|||0000-0002-4051-0836
  • Vermeire, Severine
  • Manichanh, Chaysavanh|||0000-0002-2287-4003
Crohn's disease (CD) and ulcerative colitis (UC), the two main forms of inflammatory bowel disease (IBD), affect several million people worldwide. CD and UC are characterized by periods of clinical remission and relapse. Although IBD patients present chronic alterations of the gut microbiome, called dysbiosis, little attention has been devoted to the relapse-related microbiome. To address this gap, we generated shotgun metagenomic data from the stools of two European cohorts-134 Spanish (followed up for one year) and 49 Belgian (followed up for 6 months) subjects-to characterize the microbial taxonomic and metabolic profiles present. To assess the predictive value of microbiome data, we added the taxonomic profiles generated from a previous study of 130 Americans. Our results revealed that CD was more dysbiotic than UC compared to healthy controls (HC) and that strategies for energy extraction and propionate production were different in CD compared to UC and HC. Remarkably, CD and UC relapses were not associated with alpha- or beta-diversity, or with a dysbiotic score. However, CD relapse was linked to alterations at the species and metabolic pathway levels, including those involved in propionate production. The random forest method using taxonomic profiles allowed the prediction of CD vs. non-CD with an AUC = 0.938, UC vs. HC with an AUC = 0.646, and CD relapse vs. remission with an AUC = 0.769. Our study validates previous taxonomic findings, points to different relapse-related growth and defence mechanisms in CD compared to UC and HC and provides biomarkers to discriminate IBD subtypes and predict disease activity.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Assessment of prenatal cerebral and cardiac metabolic changes in a rabbit model of fetal growth restriction based on 13 C-labelled substrate infusions and ex vivo multinuclear HRMAS

  • Simoes, Rui Vasco|||0000-0001-7574-4723
  • Cabañas Egaña, Miquel|||0000-0003-0104-0197
  • Loreiro, Carla
  • Illa, Miriam
  • Crispi, Fatima|||0000-0002-7422-5240
  • Gratacós, Eduard|||0000-0002-7405-7224
We have used a previously reported rabbit model of fetal growth restriction (FGR), reproducing perinatal neurodevelopmental and cardiovascular impairments, to investigate the main relative changes in cerebral and cardiac metabolism of term FGR fetuses during nutrient infusion. FGR was induced in 9 pregnant New Zealand rabbits at 25 days of gestation: one horn used as FGR, by partial ligation of uteroplacental vessels, and the contralateral as control (appropriate for gestation age, AGA). At 30 days of gestation, fasted mothers under anesthesia were infused i.v. with 1- 13 C-glucose (4 mothers), 2- 13 C-acetate (3 mothers), or not infused (2 mothers). Fetal brain and heart samples were quickly harvested and frozen down. Brain cortex and heart apex regions from 30 fetuses were studied ex vivo by HRMAS at 4°C, acquiring multinuclear 1D and 2D spectra. The data were processed, quantified by peak deconvolution or integration, and normalized to sample weight. Most of the total 13 C-labeling reaching the fetal brains/hearts (80-90%) was incorporated to alanine and lactate (cytosol), and to the glutamine-glutamate pool (mitochondria). Acetate-derived lactate (Lac C2C3) had a slower turnover in FGR brains (~ -20%). In FGR hearts, mitochondrial turnover of acetate-derived glutamine (Gln C4) was slower (-23%) and there was a stronger accumulation of phospholipid breakdown products (glycerophosphoethanolamine and glycerophosphocholine, +50%), resembling the profile of non-infused control hearts. Our results indicate specific functional changes in cerebral and cardiac metabolism of FGR fetuses under nutrient infusion, suggesting glial impairment and restricted mitochondrial metabolism concomitant with slower cell membrane turnover in cardiomyocytes, respectively. These prenatal metabolic changes underlie neurodevelopmental and cardiovascular problems observed in this FGR model and in clinical patients, paving the way for future studies aimed at evaluating metabolic function postnatally and in response to stress and/or treatment.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Intercontinental Gut Microbiome Variances in IBD

  • Mayorga, Luis
  • Serrano-Gómez, Gerard|||0000-0002-9447-3778
  • Xie, Zixuan|||0000-0002-8208-111X
  • Borruel, Natalia|||0000-0002-4449-2292
  • Manichanh, Chaysavanh|||0000-0002-2287-4003
The development of biomarkers for inflammatory bowel disease (IBD) diagnosis would be relevant in a generalized context. However, intercontinental investigation on these microbial biomarkers remains scarce. We examined taxonomic microbiome variations in IBD using published DNA shotgun metagenomic data. For this purpose, we used sequenced data from our previous Spanish Crohn's disease (CD) and ulcerative colitis (UC) cohort, downloaded sequence data from a Chinese CD cohort, and downloaded taxonomic and functional profiling tables from a USA CD and UC cohort. At the global level, geographical location and disease phenotype were the main explanatory covariates of microbiome variations. In healthy controls (HC) and UC, geography turned out to be the most important factor, while disease intestinal location was the most important one in CD. Disease severity correlated with lower alpha-diversity in UC but not in CD. Across geography, alpha-diversity was significantly different independently of health status, except for CD. Despite recruitment from different countries and with different disease severity scores, CD patients may harbor a very similar microbial taxonomic profile. Our study pointed out that geographic location, disease activity status, and other environmental factors are important contributing factors in microbiota changes in IBD. We therefore strongly recommend taking these factors into consideration for future IBD studies to obtain globally valid and reproducible biomarkers.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

The Interplay between Pathophysiological Pathways in Early-Onset Severe Preeclampsia Unveiled by Metabolomics

  • Youssef, Lina|||0000-0002-0554-5507
  • Crovetto, Francesca|||0000-0003-0140-7411
  • Simoes, Rui Vasco|||0000-0001-7574-4723
  • Miranda, Jezid|||0000-0003-0372-8374
  • Paules, Cristina|||0000-0001-6795-0367
  • Blasco Pelicano, Miquel|||0000-0003-0789-7992
  • Palomo, Marta|||0000-0002-3261-6577
  • García Calderó, Héctor|||0000-0002-8801-6394
  • Tura-Ceide, Olga|||0000-0003-4334-9790
  • Dantas, A. P|||0000-0001-8514-4094
  • Hernández-Gea, Virginia|||0000-0001-7937-984X
  • Herrero, Pol|||0000-0002-8746-7214
  • Canela, Núria|||0000-0003-0261-2396
  • Campistol Plana, Josep M.|||0000-0002-6841-1119
  • Garcia Pagan, Joan Carles
  • Diaz-Ricart, Maribel|||0000-0003-1122-0052
  • Gratacós, Eduard|||0000-0002-7405-7224
  • Crispi, Fatima|||0000-0002-7422-5240
Introduction: Preeclampsia is a multi-system disorder unique to pregnancy responsible for a great part of maternal and perinatal morbidity and mortality. The precise pathogenesis of this complex disorder is still unrevealed. Methods: We examined the pathophysiological pathways involved in early-onset preeclampsia, a specific subgroup representing its most severe presentation, using LC-MS/MS metabolomic analysis based on multi-level extraction of lipids and small metabolites from maternal blood samples, collected at the time of diagnosis from 14 preeclamptic and six matched healthy pregnancies. Statistical analysis comprised multivariate and univariate approaches with the application of over representation analysis to identify differential pathways. Results: A clear difference between preeclamptic and control pregnancies was observed in principal component analysis. Supervised multivariate analysis using orthogonal partial least square discriminant analysis provided a robust model with goodness of fit (R X = 0.91, p = 0.002) and predictive ability (Q Y = 0.72, p < 0.001). Finally, univariate analysis followed by 5% false discovery rate correction indicated 82 metabolites significantly altered, corresponding to six overrepresented pathways: (1) aminoacyl-tRNA biosynthesis; (2) arginine biosynthesis; (3) alanine, aspartate and glutamate metabolism; (4) D-glutamine and D-glutamate metabolism; (5) arginine and proline metabolism; and (6) histidine metabolism. Conclusion: Metabolomic analysis focusing specifically on the early-onset severe form of preeclampsia reveals the interplay between pathophysiological pathways involved in this form. Future studies are required to explore new therapeutic approaches targeting these altered metabolic pathways in early-onset preeclampsia.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A diabetic milieu increases ACE2 expression and cellular susceptibility to SARS-CoV-2 infections in human kidney organoids and patient cells

  • Garreta, Elena|||0000-0002-1071-9794
  • Prado, Patricia|||0000-0003-2225-9948
  • Stanifer, Megan|||0000-0002-5606-1297
  • Monteil, Vanessa|||0000-0002-2652-5695
  • Marco Giménez, Andrés|||0000-0002-9831-8433
  • Ullate-Agote, Asier|||0000-0002-8595-7703
  • Moya Rull, Daniel|||0000-0002-3555-6477
  • Vilas-Zornoza, Amaia|||0000-0001-6693-0989
  • Tarantino, Carolina|||0000-0003-2470-3803
  • Romero, Juan Pablo|||0000-0002-0441-4791
  • Jonsson, Gustav|||0000-0001-6692-8395
  • Oria, Roger
  • Leopoldi, Alexandra
  • Hagelkruys, Astrid
  • Gallo, Maria|||0000-0001-9099-7235
  • González Grassi, Federico|||0000-0002-7147-2246
  • Domingo Pedrol, Pedro|||0000-0003-1138-5770
  • Gavaldà i Navarro, Aleix|||0000-0001-8421-3174
  • Hurtado del Pozo, Carmen
  • Hasan Ali, Omar|||0000-0001-5185-7520
  • Ventura-Aguiar, Pedro|||0000-0003-3381-7503
  • Campistol Plana, Josep M.|||0000-0002-6841-1119
  • Prosper, Felipe|||0000-0001-6115-8790
  • Mirazimi, Ali|||0000-0003-2371-6055
  • Boulant, Steeve|||0000-0001-8614-4993
  • Penninger, Josef|||0000-0002-8194-3777
  • Montserrat, Nuria
It is not well understood why diabetic individuals are more prone to develop severe COVID-19. To this, we here established a human kidney organoid model promoting early hallmarks of diabetic kidney disease development. Upon SARS-CoV-2 infection, diabetic-like kidney organoids exhibited higher viral loads compared with their control counterparts. Genetic deletion of the angiotensin-converting enzyme 2 (ACE2) in kidney organoids under control or diabetic-like conditions prevented viral detection. Moreover, cells isolated from kidney biopsies from diabetic patients exhibited altered mitochondrial respiration and enhanced glycolysis, resulting in higher SARS-CoV-2 infections compared with non-diabetic cells. Conversely, the exposure of patient cells to dichloroacetate (DCA), an inhibitor of aerobic glycolysis, resulted in reduced SARS-CoV-2 infections. Our results provide insights into the identification of diabetic-induced metabolic programming in the kidney as a critical event increasing SARS-CoV-2 infection susceptibility, opening the door to the identification of new interventions in COVID-19 pathogenesis targeting energy metabolism.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Patient-centered care in Coronary Heart Disease, what do you want to measure? A systematic review of reviews on patient-reported outcome measures

  • Pardo Cladellas, Yolanda|||0000-0003-4982-5495
  • Garin, Olatz|||0000-0001-6193-0779
  • Oriol, Cristina|||0000-0003-4592-4832
  • Zamora, Víctor|||0000-0003-2061-0052
  • Ribera, A.|||0000-0002-2604-6328
  • Ferrer Forés, Maria Montserrat|||0000-0001-9867-7391
The number of published articles on Patient-Reported Outcomes Measures (PROMs) in Coronary Heart Disease (CHD), a leading cause of disability-adjusted life years lost worldwide, has been growing in the last decades. The aim of this study was to identify all the disease-specific PROMs developed for or used in CHD and summarize their characteristics (regardless of the construct), to facilitate the selection of the most adequate one for each purpose. A systematic review of reviews was conducted in MEDLINE, Scopus, and the Cochrane Database of Systematic Reviews. PROQOLID and BiblioPRO libraries were also checked. PROMs were classified by construct and information was extracted from different sources regarding their main characteristics such as aim, number of items, specific dimensions, original language, and metric properties that have been assessed. After title and abstract screening of 1224 articles, 114 publications were included for full text review. Finally, we identified 56 PROMs: 12 symptoms scales, 3 measuring functional status, 21 measuring Health-Related Quality of Life (HRQL), and 20 focused on other constructs. Three of the symptoms scales were specifically designed for a study (no metric properties evaluated), and only five have been included in a published study in the last decade. Regarding functional status, reliability and validity have been assessed for Duke Activity Index and Seattle Angina Questionnaire, which present multiple language versions. For HRQL, most of the PROMs included physical, emotional, and social domains. Responsiveness has only been evaluated for 10 out the 21 HRQL PROMs identified. Other constructs included psychological aspects, self-efficacy, attitudes, perceptions, threats and expectations about the treatment, knowledge, adjustment, or limitation for work, social support, or self-care. There is a wide variety of instruments to assess the patients' perspective in CHD, covering several constructs. This is the first systematic review of specific PROMs for CHD including all constructs. It has practical significance, as it summarizes relevant information that may help clinicians, researchers, and other healthcare stakeholders to choose the most adequate instrument for promoting shared decision making in a trend towards value-based healthcare. The online version contains supplementary material available at 10.1007/s11136-022-03260-6.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

The E1a Adenoviral Gene Upregulates the Yamanaka Factors to Induce Partial Cellular Reprogramming

  • Mendoza, Gracia|||0000-0003-2293-363X
  • González-Pastor, Rebeca|||0000-0002-5630-6645
  • Sánchez, Juan Miguel|||0000-0003-2108-658X
  • Arce Cerezo, Altamira
  • Quintanilla, Miguel|||0000-0002-2124-7657
  • Moreno-Bueno, Gema|||0000-0002-5030-6687
  • Pujol i Altarriba, Anna|||0000-0002-3484-598X
  • Belmar-López, Carolina
  • de Martino, Alba
  • Riu, Efrén|||0000-0002-2574-3578
  • Rodriguez, Tristan A.
  • Martin-Duque, Pilar|||0000-0003-2890-7846
The induction of pluripotency by enforced expression of different sets of genes in somatic cells has been achieved with reprogramming technologies first described by Yamanaka's group. Methodologies for generating induced pluripotent stem cells are as varied as the combinations of genes used. It has previously been reported that the adenoviral E1a gene can induce the expression of two of the Yamanaka factors (c-Myc and Oct-4) and epigenetic changes. Here, we demonstrate that the E1a-12S over-expression is sufficient to induce pluripotent-like characteristics closely to epiblast stem cells in mouse embryonic fibroblasts through the activation of the pluripotency gene regulatory network. These findings provide not only empirical evidence that the expression of one single factor is sufficient for partial reprogramming but also a potential mechanistic explanation for how viral infection could lead to neoplasia if they are surrounded by the appropriate environment or the right medium, as happens with the tumorogenic niche.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

FunOMIC, Pipeline with built-in fungal taxonomic and functional databases for human mycobiome profiling

  • Xie, Zixuan|||0000-0002-8208-111X
  • Manichanh, Chaysavanh|||0000-0002-2287-4003
While analysis of the bacterial microbiome has become routine, that of the fungal microbiome is still hampered by the lack of robust databases and bioinformatic pipelines. Here, we present FunOMIC, a pipeline with built-in taxonomic (1.6 million marker genes) and functional (3.4 million non-redundant fungal proteins) databases for the identification of fungi. Applied to more than 2,600 human metagenomic samples, the tool revealed fungal species associated with geography, body sites, and diseases. Correlation network analysis provided new insights into inter-kingdom interactions. With this pipeline and two of the most comprehensive fungal databases, we foresee a fast-growing resource for mycobiome studies.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Integrating Dietary Data into Microbiome Studies, A Step Forward for Nutri-Metaomics

  • Yañez, Francisca|||0000-0003-1877-4250
  • Soler, Zaida|||0000-0003-1709-8721
  • Oliero, Manon|||0000-0001-7865-7908
  • Xie, Zixuan|||0000-0002-8208-111X
  • Oyarzun, Iñigo
  • Serrano-Gómez, Gerard|||0000-0002-9447-3778
  • Manichanh, Chaysavanh|||0000-0002-2287-4003
Diet is recognised as the main driver of changes in gut microbiota. However, linking habitual dietary intake to microbiome composition and activity remains a challenge, leaving most microbiome studies with little or no dietary information. To fill this knowledge gap, we conducted two consecutive studies (n = 84: a first pilot study (n = 40) to build a web-based, semi-quantitative simplified FFQ (sFFQ) based on three 24-h dietary recalls (24HRs); a second study (n = 44) served to validate the newly developed sFFQ using three 24HRs as reference method and to relate gut microbiome profiling (16S rRNA gene) with the extracted dietary and lifestyle data. Relative validation analysis provided acceptable classification and agreement for 13 out of 24 (54%) food groups and 20 out of 29 nutrients (69%) based on intraclass correlation coefficient, cross-classification, Spearman's correlation, Wilcoxon test, and Bland-Altman. Microbiome analysis showed that higher diversity was positively associated with age, vaginal birth, and intake of fruit. In contrast, microbial diversity was negatively associated with BMI, processed meats, ready-to-eat meals, sodium, and saturated fat. Our analysis also revealed a correlation between food groups or nutrients and microbial composition. Overall, we provide the first dietary assessment tool to be validated and correlated with microbiome data for population studies.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

GSR-DB: a manually curated and optimized taxonomical database for 16S rRNA amplicon analysis

  • González Molano, Leidy Alejandra
  • Vega Abellaneda, Sara
  • Chaysavanh, Manichanh
Database; Microbiome; Taxonomy, Base de datos; Microbioma; Taxonomía, Base de dades; Microbioma; Taxonomia, Amplicon-based 16S ribosomal RNA sequencing remains a widely used method to profile microbial communities, especially in low biomass samples, due to its cost-effectiveness and low-complexity approach. Reference databases are a mainstay for taxonomic assignments, which typically rely on popular databases such as SILVA, Greengenes, Genome Taxonomy Database (GTDB), or Ribosomal Database Project (RDP). However, the inconsistency of the nomenclature across databases and the presence of shortcomings in the annotation of these databases are limiting the resolution of the analysis. To overcome these limitations, we created the GSR database (Greengenes, SILVA, and RDP database), an integrated and manually curated database for bacterial and archaeal 16S amplicon taxonomy analysis. Unlike previous integration approaches, this database creation pipeline includes a taxonomy unification step to ensure consistency in taxonomical annotations. The database was validated with three mock communities, two real data sets, and a 10-fold cross-validation method and compared with existing 16S databases such as Greengenes, Greengenes 2, GTDB, ITGDB, SILVA, RDP, and MetaSquare. Results showed that the GSR database enhances taxonomical annotations of 16S sequences, outperforming current 16S databases at the species level, based on the evaluation of the mock communities. This was confirmed by the 10-fold cross-validation, except for Greengenes 2. The GSR database is available for full-length 16S sequences and the most commonly used hypervariable regions: V4, V1–V3, V3–V4, and V3–V5. IMPORTANCE Taxonomic assignments of microorganisms have long been hindered by inconsistent nomenclature and annotation issues in existing databases like SILVA, Greengenes, Greengenes2, Genome Taxonomy Database, or Ribosomal Database Project. To overcome these issues, we created Greengenes-SILVA-RDP database (GSR-DB), accurate and comprehensive taxonomic annotations of 16S amplicon data. Unlike previous approaches, our innovative pipeline includes a unique taxonomy unification step, ensuring consistent and reliable annotations. Our evaluation analyses showed that GSR-DB outperforms existing databases in providing species-level resolution, especially based on mock-community analysis, making it a game-changer for microbiome studies. Moreover, GSR-DB is designed to be accessible to researchers with limited computational resources, making it a powerful tool for scientists across the board. Available for full-length 16S sequences and commonly used hypervariable regions, including V4, V1–V3, V3–V4, and V3–V5, GSR-DB is a go-to database for robust and accurate microbial taxonomy analysis., This work was supported by the Instituto de Salud Carlos III/FEDER (PI20/00130). Funding for open access charge was provided by Instituto de Salud Carlos III/FEDER.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Distinct microbial mediators link diet to inflammation in Crohn’s disease and ulcerative colitis

  • Campderros, Laura
  • Pons Tarín, Marc
  • Mayorga Ayala, Luis Fernando
  • Noguera Segura, Arnau
  • Soler, Zaida
  • Vega Abellaneda, Sara
  • Serrano Gómez, Gerard
  • Herrera-deGuise, Claudia
  • robles, virginia
  • BORRUEL, NATALIA
  • Chaysavanh, Manichanh
Crohn's disease; Ulcerative colitis, Enfermedad de Crohn; Colitis ulcerosa, Malaltia de Crohn; Colitis ulcerosa, Background Inflammatory bowel disease (IBD) arises from complex interactions among diet, host and gut microbiome. Although diet influences intestinal inflammation, the microbial and metabolic pathways involved, and their differences between Crohn’s disease (CD) and ulcerative colitis (UC), the two main subtypes of IBD remain unclear. Objective To investigate how the gut microbiome mediates the effects of habitual diet on inflammatory activity in IBD. Design This longitudinal study included 198 adults (100 healthy controls, 49 CD, 49 UC), participants completed a validated food frequency questionnaire. Dietary quality was evaluated using established indices (Alternative Mediterranean Diet, Healthy Eating Index-2015, Índice de Alimentación Saludable, Mean Adequacy Ratio, Plant-Based Dietary Indexes, Healthy Food Diversity). Participants also provided two stool samples (baseline and 6 months). Shotgun metagenomics (n=366) enabled taxonomic and functional profiling. Causal mediation analyses were used to identify microbial features mediating the effect of diet on inflammation. Results IBD patients exhibited lower dietary diversity, fibre intake and nutritional adequacy compared with controls. Microbiome diversity was lowest in CD, intermediate in UC and correlated positively with higher intake of fibre, fruit, vegetables and nuts, and negative with processed foods and sugary beverages. Causal mediation analyses revealed that in CD, coffee, whole wheat bread and healthier diets lowered the Harvey-Bradshaw index through specific bacterial species and metabolites. In UC, Mediterranean-like diets, fruits and coffee reduced C reactive protein via greater microbial richness, reduced dysbiosis and short-chain fatty acid-related functions. Conclusion Diet quality influences inflammation in IBD through distinct microbiome pathways: specific taxa and metabolites mediate effects in CD, whereas microbial richness and global composition drive protection in UC. Data availability statement Data are available upon reasonable request. The data generated in this study are available within this manuscript and its Supplementary Information. Analytic methods, study materials and sequencing data will be made available by the corresponding author upon reasonable request. Due to patient confidentiality, the metadata are available upon reasonable request., This work was financially supported by Spanish institutions: the Instituto de Salud Carlos III and co-funded by the European Union (ERDF/ESF, 'A way to make Europe'/'Investing in your future' (PI20/00130), the Ministry of Economy and Competitiveness (MINECO), with co-funding from FEDER (E.U.) (PID23-147387OB-100) and the AGAUR (2021 SGR 00459). None of the funders were private companies.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

The Effect of Probiotics on Preterm Birth Rates in Pregnant Women After a Threatened Preterm Birth Episode (The PROPEV Trial)

  • Miserachs Sala, Marta
  • Puerto Tamayo , Linda Grace
  • Garrido-Giménez, Carmen
  • Soler, Zaida
  • Dalmau Artal, Marta
  • Casellas de Miguel, Alba
  • Carreras, Elena
  • Goya, Maria
  • del Barco Martínez, Ester
  • González Molano, Leidy Alejandra
  • VARGAS BUJÁN, MIREIA
  • Chaysavanh, Manichanh
Microbiota; Preterm birth; Probiotics, Microbiota; Parto prematuro; Probióticos, Microbiota; Part prematur; Probiòtics, Introduction: Preterm birth is the leading cause of perinatal mortality worldwide, with prevalence rates showing little reduction. Although mortality rates have decreased, morbidity rates remain concerningly high. In recent years, there has been a surge in studies examining the etiology, risk factors, and management of preterm birth. The use of vaginal probiotics in pregnant women at risk of preterm birth has garnered attention as a potential approach for improving perinatal outcomes and modulating the vaginal microbiota. However, the efficacy of this intervention remains unclear. Therefore, this study explored the impact of vaginal probiotics on perinatal outcomes and vaginal microbiota composition in pregnant women at risk of preterm birth. Materials and Methods: This was a randomized, prospective, longitudinal, double-blind, placebo-controlled, multicentric trial conducted across seven maternities in Spain from October 2017 to August 2022 in pregnant women at risk of preterm birth. Participants were randomly assigned to receive vaginal probiotics containing four lactobacilli strains or a placebo. The primary outcome was to explore a potential correlation between probiotic use among pregnant women at risk of preterm birth and the actual rate of preterm birth before 37 gestational weeks. Secondary outcomes included an evaluation of preterm birth rates, neonatal morbidity, the vaginal microbiota, and changes in the vaginal microbiota after receiving probiotics. Other secondary outcomes were identifying vaginal microbiota patterns associated with preterm birth and exploring potential therapeutic mechanisms involving probiotics. Trial registration: Clinicaltrials.gov, identifier: NCT03689166. Results: A total of 200 participants were included. Of those, birth data were obtained for 181 women. Demographics were similar between both groups. An analysis of perinatal outcomes found no significant differences in preterm birth rates, prematurity rates, gestational weeks at delivery, neonatal complications, time to birth, or latency time to delivery. Microbiota analysis showed no significant differences in vaginal microbiota changes between groups. No serious or unexpected adverse reactions were reported. Conclusions: There were no statistically significant differences for spontaneous preterm birth between pregnant women receiving probiotics and pregnant women receiving the placebo., This work was supported by the Spanish Clinical Research Network (SCReN), which is funded by the ISCIII-General Subdirectorate for Evaluation and Promotion of Research through projects PT17/0017/0030 and PT20/00078. Both projects were integrated into the 2013–2016 National Plan for Scientific and Technical Research and Innovation and co-financed by the European Regional Development Fund (ERDF), “A way of making Europe”. This work was also supported by Project FIS PI 19/00287 (Maria Goya as a principal investigator), which was funded by Instituto de Salud Carlos III (ISCIII) and co-funded by the European Union. Laboratorios Ordesa S.L funded the PROPEV study. L.-A.G.M. was supported by Instituto de Salud Carlos III/FEDER (PI20/00130).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Targeting the Warburg Effect in Cancer: Where Do We Stand?

  • Carrillo-Bosch, Laura
  • Barba, Ignasi
  • Seoane, Joan
Warburg effect; Aerobic glycolysis; Tumor metabolism, Efecto Warburg; Glucólisis aeróbica; Metabolismo tumoral, Efecte Warburg; Glucòlisi aeròbica; Metabolisme tumoral, The Warburg effect, characterized by the preferential conversion of glucose to lactate even in the presence of oxygen and functional mitochondria, is a prominent metabolic hallmark of cancer cells and has emerged as a promising therapeutic target for cancer therapy. Elevated lactate levels and acidic pH within the tumor microenvironment (TME) resulting from glycolytic profoundly impact various cellular populations, including macrophage reprogramming and impairment of T-cell functionality. Altogether, the Warburg effect has been shown to promote tumor progression and immunosuppression through multiple mechanisms. This review provides an overview of the current understanding of the Warburg effect in cancer and its implications. We summarize recent pharmacological strategies aimed at targeting glycolytic enzymes, highlighting the challenges encountered in achieving therapeutic efficacy. Additionally, we examine the utility of the Warburg effect as an early diagnostic tool. Finally, we discuss the multifaceted roles of lactate within the TME, emphasizing its potential as a therapeutic target to disrupt metabolic interactions between tumor and immune cells, thereby enhancing anti-tumor immunity., The study was undertaken with the support of the Fundación Asociación Española contra el Cáncer (AECC), the ISCIII, FIS (PI22/00130), BBVA (CAIMI), and Cellex Foundation.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

FunOMIC: Pipeline with built-in fungal taxonomic and functional databases for human mycobiome profiling

  • Manichanh, Chaysavanh
  • Xie, Zixuan
Fungal databases; Taxonomy and functions; Inter-kingdom interactions, Bases de datos de hongos; Taxonomía y funciones; Interacciones entre reinos, Bases de dades de fongs; Taxonomia i funcions; Interaccions entre regnes, While analysis of the bacterial microbiome has become routine, that of the fungal microbiome is still hampered by the lack of robust databases and bioinformatic pipelines. Here, we present FunOMIC, a pipeline with built-in taxonomic (1.6 million marker genes) and functional (3.4 million non-redundant fungal proteins) databases for the identification of fungi. Applied to more than 2,600 human metagenomic samples, the tool revealed fungal species associated with geography, body sites, and diseases. Correlation network analysis provided new insights into inter-kingdom interactions. With this pipeline and two of the most comprehensive fungal databases, we foresee a fast-growing resource for mycobiome studies., This work was supported by the European Union’s Horizon 2020 research and innovation program under the Marie Sklodowska-Curie Action, Innovative Training Network [grant number 812969] and by the Instituto de Salud Carlos III /FEDER, a government agency (Grant No: PI17/00614; PI20/00130).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Microbiome multi-omics analysis reveals novel biomarkers and mechanisms linked with CD etiopathology

  • Soler Luque, Zaida
  • Pons Tarín, Marc
  • Mayorga Ayala, Luis Fernando
  • Consegal, Marta
  • Manjon, Isaac
  • Serrano Gómez, Gerard
  • Yañez, Francisca
  • Herrera-deGuise, Claudia
  • BORRUEL, NATALIA
  • Rodriguez-Sinovas, Antonio
  • Vega Abellaneda, Sara
  • Chaysavanh, Manichanh
Inflammatory bowel disease; Microbiome; Multi-omics, Enfermedad inflamatoria intestinal; Microbioma; Multiómica, Malaltia inflamatòria intestinal; Microbioma; Multiòmica, Background The gut microbiome plays a key role in the development of inflammatory bowel disease (IBD), as imbalances in microbial composition are associated with immune dysfunction. However, the specific mechanisms by which certain microorganisms contribute to this process remain unclear. Methods Here, we employed a multi-omics approach on fecal samples to identify novel microbiome markers and elucidate mechanisms underlying IBD. Shotgun metagenomics was applied to 212 samples (850 in total with validation cohort), shotgun metatranscriptomics to 103 samples and metabolomics to 105 samples. Machine learning techniques were used to predict disease and the three omics data were integrated to propose a mechanistic role of the microbiota. Results Metagenomic analysis identified Crohn's disease (CD)-specific microbiome signatures, including a panel of 20 species that achieved a high diagnostic performance, with an area under the ROC curve (AUC) of 0.94 in an external validation set. Metatranscriptomic analysis revealed significant alterations in microbial fermentation pathways in CD, but not in ulcerative colitis (UC), highlighting disruptions that explain the depletion of butyrate—a key anti-inflammatory metabolite—observed in metabolomics analysis. Integrative multi-omics analyses further identified active virulence factor genes in CD, predominantly originating from the adherent-invasive Escherichia coli (AIEC). Notably, these findings unveiled novel mechanisms, including E. coli-mediated aspartate depletion and the utilization of propionate, which drives the expression of the ompA virulence gene, critical for bacterial adherence and invasion of the host’s macrophages. Interestingly, these microbiome alterations were absent in UC, underscoring distinct mechanisms of disease development between the two IBD subtypes. Conclusions In conclusion, our study not only identifies promising novel biomarkers with strong diagnostic potential, which could be valuable in challenging clinical scenarios, but also offers an integrated multi-omics perspective on the microbial mechanisms underlying inflammation and virulence in Crohn's disease., This work was supported by the Instituto de Salud Carlos III/FEDER (PI20/00130; FI21/00262). Marc Pons and Sara Vega-Abellaneda were supported by the AGAUR (2021 SGR 00459). Francisca Yáñez was supported by a fellowship from ANID, BECAS Chile, No. 72190278.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Integrating Dietary Data into Microbiome Studies: A Step Forward for Nutri-Metaomics

  • Yañez Araya, Francisca
  • Soler Luque, Zaida
  • Oliero, Manon
  • Oyarzun Lafuente, Iñigo
  • Serrano Gomez, Gerard
  • Manichanh, Chaysavanh
  • Xie, Zixuan
Relación dieta-microbioma; Validación relativa; Desarrollo de sFFQ, Relació dieta-microbioma; Validació relativa; Desenvolupament sFFQ, Diet–microbiome relationship; Relative validation; sFFQ development, Diet is recognised as the main driver of changes in gut microbiota. However, linking habitual dietary intake to microbiome composition and activity remains a challenge, leaving most microbiome studies with little or no dietary information. To fill this knowledge gap, we conducted two consecutive studies (n = 84: a first pilot study (n = 40) to build a web-based, semi-quantitative simplified FFQ (sFFQ) based on three 24-h dietary recalls (24HRs); a second study (n = 44) served to validate the newly developed sFFQ using three 24HRs as reference method and to relate gut microbiome profiling (16S rRNA gene) with the extracted dietary and lifestyle data. Relative validation analysis provided acceptable classification and agreement for 13 out of 24 (54%) food groups and 20 out of 29 nutrients (69%) based on intraclass correlation coefficient, cross-classification, Spearman’s correlation, Wilcoxon test, and Bland–Altman. Microbiome analysis showed that higher diversity was positively associated with age, vaginal birth, and intake of fruit. In contrast, microbial diversity was negatively associated with BMI, processed meats, ready-to-eat meals, sodium, and saturated fat. Our analysis also revealed a correlation between food groups or nutrients and microbial composition. Overall, we provide the first dietary assessment tool to be validated and correlated with microbiome data for population studies., This study was supported by grants from by the Instituto de Salud Carlos III/FEDER (PI17/00614; PI20/00130), a government agency. Francisca Yáñez was supported by a fellowship from ANID, BECAS Chile, No. 72190278. Zixuan Xie received a fellowship from the European Union’s Horizon 2020 research and innovation program under the Marie Sklodowska-Curie Action, Innovative Training Network: FunHoMic; grant number 812969.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Patient-derived preclinical models to develop immunotherapies

  • Seoane, Joan
Immuno-oncology; Preclinical models; Tumor microenvironment, Inmuno-oncología; Modelos preclínicos; Microambiente tumoral, Immuno-oncologia; Models preclínics; Microambient tumoral, Cancer immunotherapy has revolutionized the treatment of some malignancies. Yet, many tumors do not unfortunately respond to immune-based therapies. Deeper insights into the biology of the immune response to cancer are required to identify novel therapeutic targets and advance immuno-oncology. To do so, we need to study cancer in patient-derived models that can faithfully recapitulate and capture the complexity and heterogeneity of the tumor immune ecosystem. Platforms facilitating the analysis of the human tumor immune microenvironment of individual patients are crucial. Patient-derived models are fundamental not only to better understand the biology of the cancer immune system but also to discern the mechanism of action of therapeutic compounds and perform preclinical studies toward improving the success of subsequent clinical testing. In this viewpoint, I present a brief review of patient-derived models for cancer immunotherapy., Fundación Asociación Española Contra el Cáncer (AECC). Cellex Foundation. BBVA (CAIMI). ISCIII FIS. Grant Number: PI22 00130
e_Buah Biblioteca Digital Universidad de Alcalá
Publication Artículo científico (JournalArticle)

Adaptive immune response during hepatitis C virus infection

  • Larrubia Marfil, Juan Ramón
  • Moreno Cubero, Elia
  • Lokhande, Megha Uttam
  • García Garzón, Silvia
  • Lázaro López, Alicia
  • Miquel, Joaquín
  • Perna Monroy, Luis Cristian|||0000-0001-8566-1198
  • Sanz de Villalobos, Eduardo
20 p., Hepatitis C virus (HCV) infection affects about 170 million people worldwide and it is a major cause of liver cirrhosis and hepatocellular carcinoma. HCV is a hepatotropic non-cytopathic virus able to persist in a great percentage of infected hosts due to its ability to escape from the immune control. Liver damage and disease progression during HCV infection are driven by both viral and host factors. Specifically, adaptive immune response carries out an essential task in controlling non-cytopathic viruses because of its ability to recognize infected cells and to destroy them by cytopathic mechanisms and to eliminate the virus by non-cytolytic machinery. HCV is able to impair this response by several means such as developing escape mutations in neutralizing antibodies and in T cell receptor viral epitope recognition sites and inducing HCV-specific cytotoxic T cell anergy and deletion. To impair HCV-specific T cell reactivity, HCV affects effector T cell regulation by modulating T helper and Treg response and by impairing the balance between positive and negative co-stimulatory molecules and between pro- and anti-apoptotic proteins. In this review, the role of adaptive immune response in controlling HCV infection and the HCV mechanisms to evade this response are reviewed., Instituto de Salud Carlos III (ISCIII), Fondo Europeo de Desarrollo Regional (FEDER), Fundación de Investigación Médica Mutua Madrileña, Asociación de Hepatología Translacional
e_Buah Biblioteca Digital Universidad de Alcalá
Publication Artículo científico (JournalArticle)

Specific CD8(+) T cell response immunotherapy for hepatocellular carcinoma and viral hepatitis

  • Moreno Cubero, Elia
  • Larrubia Marfil, Juan Ramón
Hepatocellular carcinoma (HCC), chronic hepatitis B (CHB) and chronic hepatitis C (CHC) are characterized by exhaustion of the specific CD8+ T cell response. This process involves enhancement of negative costimulatory molecules, such as programmed cell death protein-1 (PD-1), cytotoxic T-lymphocyte antigen-4 (CTLA-4), 2B4, Tim-3, CD160 and LAG-3, which is linked to intrahepatic overexpression of some of the cognate ligands, such as PD-L1, on antigen presenting cells and thereby favouring a tolerogenic environment. Therapies that disrupt these negative signalling mechanisms represent promising therapeutic tools with the potential to restore reactivity of the specific CD8+ T cell response. In this review we discuss the impressive in vitro and in vivo results that have been recently achieved in HCC, CHB and CHC by blocking these negative receptors with monoclonal antibodies against these immune checkpoint modulators. The article mainly focuses on the role of CTLA-4 and PD-1 blocking monoclonal antibodies, the first ones to have reached clinical practice. The humanized monoclonal antibodies against CTLA-4 (tremelimumab and ipilimumab) and PD-1 (nivolumab and pembrolizumab) have yielded good results in testing of HCC and chronic viral hepatitis patients. Trelimumab, in particular, has shown a significant increase in the time to progression in HCC, while nivolumab has shown a remarkable effect on hepatitis C viral load reduction. The research on the role of ipilimumab, nivolumab and pembrolizumab on HCC is currently underway., Instituto de Salud Carlos III
e_Buah Biblioteca Digital Universidad de Alcalá
Publication Artículo científico (JournalArticle)

According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1lowHCV-Specific CD8+Cell Reactivity

  • Moreno Cubero, Elia
  • Subirá, Dolores
  • Sanz de Villalobos, Eduardo
  • Parra Cid, Trinidad
  • Madejón Seiz, Antonio
  • Miquel Plaza, Joaquín
  • Olveira, Antonio
  • González Praetorius, Alejandro
  • García Samaniego, Javier
  • Larrubia Marfil, Juan Ramón
Hepatitis C virus (HCV)-specific CD8+T cells suffer a progressive exhaustion during persistent infection (PI) with HCV. This process could involve the positive immune checkpoint 4-1BB/4-1BBL through the loss of its signal transducer, TRAF1. To address this issue, peripheral HCV-specific CD8+T cells (pentamer-positive [pentamer+]/CD8+T cells) from patients with PI and resolved infection (RI) after treatment were studied. The duration of HCV infection and the liver fibrosis progression rate inversely correlated with the likelihood of detection of peripheral pentamer+/CD8+cells. In PI, pentamer+/CD8+cells had impaired antigen-specific reactivity that worsened when these cells were not detectableex vivoShort/midduration PI was characterized by detectable peripheral PD-1+CD127lowTRAF1lowcells. After triggering of T cell receptors (TCR), the TRAF1 level positively correlated with the levels of CD127, Mcl-1, and CD107a expression and proliferation intensity but negatively with PD-1 expression, linking TRAF1lowto exhaustion.In vitrotreatment with interleukin-7 (IL-7) upregulated TRAF1 expression, while treatment with transforming growth factor-β1 (TGF-β1) did the opposite, suggesting that the IL-7/TGF-β1 balance, besides TCR stimulation, could be involved in TRAF1 regulation. In fact, the serum TGF-β1 concentration was higher in patients with PI than in patients with RI, and it negatively correlated with TRAF1 expression. In line with IL-7 increasing the level of TRAF1 expression, IL-7 plus 4-1BBL treatmentin vitroenhanced T cell reactivity in patients with short/midduration infection. However, in patients with long-lasting PI, anti-PD-L1, in addition to the combination of IL-7 and 4-1BBL, was necessary to reestablish T cell proliferation in individuals with slowly progressing liver fibrosis (slow fibrosers) but had no effect in rapid fibrosers. In conclusion, a peripheral hyporeactive TRAF1lowHCV-specific CD8+T cell response, restorable by IL-7 plus 4-1BBL treatment, characterizes short/midduration PI. In long-lasting disease, HCV-specific CD8+T cells are rarely detectableex vivo, but treatment with IL-7, 4-1BBL, and anti-PD-L1 recovers their reactivityin vitroin slow fibrosers.IMPORTANCEHepatitis C virus (HCV) infects 71 million people worldwide. Two-thirds develop a chronic disease that can lead to cirrhosis and hepatocellular carcinoma. Direct-acting antivirals clear the infection, but there are still patients who relapse. In these cases, additional immunotherapy could play a vital role. A successful anti-HCV immune response depends on virus-specific CD8+T cells. During chronic infection, these cells are functionally impaired, which could be due to the failure of costimulation. This study describes exhausted specific T cells, characterized by low levels of expression of the signal transducer TRAF1 of the positive costimulatory pathway 4-1BB/4-1BBL. IL-7 upregulated TRAF1 expression and improved T cell reactivity in patients with short/midduration disease, while in patients with long-lasting infection, it was also necessary to block the negative PD-1/PD-L1 checkpoint. When the results are taken together, this work supports novel ways of restoring the specific CD8+T cell response, shedding light on the importance of TRAF1 signaling. This could be a promising target for future immunotherapy., Ministerio de Economía y Competitividad
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Multimodal minimally invasive wearable technology for epilepsy monitoring: a feasibility study of the periauricular area

  • Besné, Guillermo M.
  • Iturri López, Peio
  • Alegre, Manuel
  • Artieda, Julio
  • Trigo Vilaseca, Jesús Daniel
  • Serrano Arriezu, Luis Javier
  • Falcone Lanas, Francisco
  • Valencia Ustárroz, Miguel
Ambulatory monitoring is of great interest in both clinical and domestic environments. Despite the technological advances, few monitoring solutions are suitable for medical application and diagnosis. Here, we investigate the feasibility of targeting the periauricular area (ear pavilion, ear canal, and the surrounding skin areas) to implement a multimodal system that fulfills the requirements of ergonomics and minimal obstructiveness in the context of epilepsy monitoring. Six physiological signals are selected and explored for their integration in the area of interest and a ¿proof-of-concept¿ prototype integrating the components in a single portable device targeting the selected location is implemented. Results show mixed results where some parameters are highly reliable, and others are impractical or require customized technology to provide clinically relevant information. To enable data acquisition, storage, and processing within the Internet of Medical Things paradigms, wireless body area transceiver integration is also analyzed in terms of coverage/capacity relations, showing feasibility for such device configuration., This work was supported in part by the Department of Economic Development of the Government of Navarra under Grant GN 2019 PC078-079; in part by the Carlos III Health Institute through the project under Grant DTS19/00130 (co-financed by the European Regional Development Fund; “A way to make Europe”); and in part by the Agencia Estatal de Investigación, Fondo Europeo de Desarrollo Regional -FEDER-, European Union under Grant PID2021-127409OB-C31 CONDOR.